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Platelet surface interactions play a critical role in the hemocompatibility of 
blood contacting biomaterials. When blood leaves the natural vessel and 
contacts a synthetic material, the body senses this change. Immediately, a host 
of responses occur at the blood material interface including plasma protein 
adsorption and platelet adhesion and activation.  Platelet activation stimulates 
local coagulation factors eventually leading to the formation of a blood clot. Clot 
formation on vascular implants can have many adverse effects and ultimately 
lead to the failure of these devices. 
To date, an extensive amount of research has been focused on controlling 
surface induced platelet adhesion and activation. Although a number of studies 
have shown promising in vitro results, the translation to successful 
hemocompatible biomaterials has been somewhat limited.  This is largely due to 
the complexity behind the mechanisms driving the platelet response.    
In this dissertation, well defined microenvironments, as a function of both 
surface chemistry and protein immobilization, were used to characterize and 
understand the molecular mechanisms of surface induced platelet responses.  
Specifically, molecular gradients were investigated as a high throughput 
technique in which the platelet response could be rapidly screened over a variety 




affected the downstream platelet response and that upstream surface 
interactions may actually prime platelets for downstream adhesion and activation.  
This phenomenon was further explored using microcontact printing to prepare 
test samples with covalently immobilized fibrinogen “priming” regions. The 
downstream platelet response was characterized and found to be dependent on 
the presence of an upstream priming region.  The use of microcontact printing 
was also investigated as a tool to control platelet adhesion and morphological 
characteristics using random micropatterns of fibrinogen at varying relative 
coverage areas.   The experiments described in this dissertation provided well 
controlled environments in which specific surface-induced platelet adhesion and 
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Cardiovascular disease (CVD) is the number one killer in America.  With 
increasing life expectancy, a growing incidence of type II diabetes, and the 
epidemic proportion of obese individuals, health care professionals expect to see 
the incidence of CVD continue to rise.  According to the American Heart 
Association, approximately 40% of American‟s will have some form of CVD by 
2030 [1]. Many of these conditions cannot be effectively treated 
pharmacologically.  As a result, therapeutic cardiovascular devices such as heart 
valves, vascular grafts, and stents are often implanted as the last opportunity for 
the patient.  Regrettably, in spite of years of intensive research, the response of 
blood to these devices still presents many challenges [2,3]. Specifically, patients 
who receive cardiovascular implants are plagued with an increased risk of 
infection and surface induced thrombus formation which can ultimately lead to 
the failure of the device [4,5]. This requires that device implantation is coupled 
with the use of systematic anticoagulant and antithrombotic therapies that often 
result in adverse side effects for the patient [6,7]. 
When blood contacts the surface of a synthetic vascular prosthetic the 
body senses this change and host of responses occur at the blood-material 
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interface.  Immediately, plasma proteins adsorb to the surface of the device [8,9].  
This adsorbed protein layer serves as a bioactive coating capable of initiating 
both immunological and thrombogenic responses including, platelet 
adhesion/activation, coagulation, complement activation and inflammation (6, 
Figure 1.1).   The activation mechanisms of these systems are highly interwoven. 
For example, the biomaterial surface can directly stimulate complement 
activation and coagulation through the intrinsic pathway and extrinsic pathways 
respectively.  Biomaterials also support platelet adhesion and activation.  
Activated platelets are capable of up-regulating and mediating coagulation 
reactions as well as thrombus formation. Leukocytes are activated by both direct 
interactions with the implant surface or through interactions with activated 
platelets mounting an inflammatory response [6,10].  Platelet activation, 
specifically, has been a key focus of biomaterials research due to its central role 
in coagulation and its role in mediating inflammatory responses.  An adverse 
platelet response to vascular implants can lead to many complications including 
occlusion, neointimal hyperplasia, and embolism.   
This introduction provides an overview of the events that occur when a 
synthetic material contacts the bloodstream with a focus on platelet adhesion and 
activation. Recent advancements in improving material hemocompatibility as well 
as using surface patterning tools to better understand protein-platelet interactions 
are also reviewed.  Finally, a brief synopsis of each research project described in 













1. 1 Plasma Protein Adsorption on Biomaterials 
Over 150 plasma proteins make up approximately 7% of the total volume 
of blood and serve a variety of important functions, including maintaining osmotic 
pressure, facilitating immune responses, and mediating the coagulation 
response.  However, for cardiovascular implants, the protein response can 
ultimately lead to device failure.  Within seconds after an artificial material is 
placed into contact with the bloodstream, these proteins adsorb to the surface 
[8,9]. This adsorbed layer serves as a substrate for cell and platelet adhesion via 
specific interactions between the proteins and membrane receptors on the cell 
surface.  Adsorbed proteins can activate a multitude of intracellular responses 
and trigger adverse effects such as thrombus formation, inflammation and 
complement activation [6].  Given that the adsorbed protein layer serves as the 
primary mediator for cell-surface interactions, the nature of this layer ultimately 
dictates the host response to the implant [11].  While in some biomedical 
applications protein adsorption can be a desired result [12-14], for blood-
contacting materials, it is almost entirely detrimental. Consequently, an extensive 
amount of effort has been devoted to understanding and controlling protein 
adsorption to vascular biomaterials [15-17]. 
 
1.1.1 Surface Considerations in Protein Adsorption  
The ability of a surface to minimize protein adsorption is believed to be 
linked to improved blood compatibility; consequently, quantifying protein 
adsorption is a popular tool for material evaluation [15,18,19]. Properties such as 
surface, topography, chemistry, hydrophobicity, and charge are all critical in 
16 
 
determining protein response at the blood-material interface and subsequently, 
the host response to the device. Increased protein adsorption has been observed 
on surfaces with more topographical features than smooth surfaces [20]. This is 
believed to be due to the increased surface area available for protein adsorption 
on rough surfaces. Surface chemistry is also critical in determining the protein 
response.  The surface chemical makeup dictates the type of chemical bonds the 
protein may make with the surface.  Stronger chemical bonds between the 
protein and the interface will increase its affinity for the surface [11,20]. 
Chemistry also dictates factors such as hydrophobicity and charge.  Hydrophobic 
surfaces have been shown to adsorb proteins more readily than hydrophilic 
surfaces [21,22] due to hydrophobic interactions between the protein and the 
interface.  Plasma proteins have also been shown to adsorb less readily to 
negatively charged surfaces [23,24].  This is likely due to the fact that plasma 
proteins carry an overall net negative charge.  However, negatively charged 
surfaces alone do not completely inhibit adsorption. Plasma proteins may also 
contain positively charged regions on their surface due to the presence of amino 
acids that carry a positive charge (histidine, lysine, arginine) and therefore are 
capable of interactions with negative surfaces. 
 
1.1.2 Why are Proteins So Sticky? Properties Affecting Adsorption  
Proteins are large amphiphilic molecules and very surface active.  All 
proteins are polymeric chains built from 20 amino acids called polypeptides. 
These amino acids can be neutral or charged, hydrophobic or hydrophilic and 
ultimately determine both its structure and function.  Noncovalent interactions 
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such as hydrogen bonding, van der Waals forces and ionic/hydrophobic 
interactions drive the formation of spatial structures such as helicies, sheets, and 
turns within the polypeptide chain.  These secondary structures fold upon 
themselves forming a globular 3-dimensional structure.  Folding is initially driven 
by non specific hydrophobic interactions but maintained by specific interactions 
such as hydrogen bonding, the formation of salt bridges, and disulfide bonds 
[25,26].  The heterogeneity of protein composition makes preventing adsorption 
an extremely difficult task.   Hydrophobic amino acids, generally found in the 
inner core of a soluble protein, will interact with hydrophobic surface regions 
driving both adsorption and unfolding [11,20,2].  Charged amino acids, generally 
more hydrophilic and commonly found on the protein surface, will interact with 
oppositely charged surface regions also driving adsorption [20,23,28]. 
 Adsorption is also affected by structural properties such as size and 
stability of the protein.  As proteins increase in size, their affinity for the surface 
also increases.  This is because larger molecules are capable of making more 
contacts with the surface and subsequently more stable once adsorbed [20].  
Protein unfolding is a critical factor in biomaterial-induced protein adsorption 
since this frequently results in the exposure of cryptic binding epitopes capable of 
cell and platelet activation.  Unfolding is dependent on the structural and 
thermodynamic stability of the protein. Interactions within the protein molecule 
such as disulfide and hydrogen bonds increase stability.  The more bonds 
present within the protein, the less likely it is to unfold after adsorption. The 
thermodynamic stability or, in other words, the free energy change between the 
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folded and unfolded state also drives this process. The free energy change can 
be calculated by subtracting entropy from the binding energy of the protein. 
Dispersion forces, electrostatic interactions, van der Waals potential and 
hydrogen bonding all contribute to the binding energy while hydrophobic 
interactions are described by the entropy term.  As the binding energy increases 
or the entropy difference between the two states decreases, the folded protein is 
more stable [27].  It is believed that the hydrophobic effect or the change in 
entropy between the two states is the predominant stabilizing effect [25,27]. 
 
1.1.3 Protein Transport From the Bulk to the Biomaterial Interface 
 
In order for adsorption to occur, the protein must be transported from the 
bulk to the interface; thus, both diffusion and convection also play a role in 
adsorption.  Since smaller molecules have higher diffusion coefficients, smaller 
plasma proteins are generally the first to arrive and adsorb to interface [29]. Also, 
proteins at a higher bulk concentration generally are quick to populate the 
surface [20,29]. Over time, molecules with higher overall affinity for the surface, 
but slower diffusion rates (due to their larger size and/or lower solution 
concentration) will approach the surface and compete for binding sites.  
Although, generally, simple desorption of proteins does not occur, it is possible 
for proteins with a higher surface affinity to compete and exchange with proteins 
already present on the surface. This process is called the Vroman effect [30]. 
With over 150 proteins in plasma, adsorption kinetics are complex but also 
critical in determining the nature of the protein layer.  The rate at which a protein 
adsorbs to a surface can affect both its conformation and orientation on the 
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surface.  At high concentrations, adsorption is fast, making it likely that after initial 
adsorption, the binding site next to it will also be populated before the protein has 
a chance to unfold.  The faster the protein arrives the smaller the footprint 
[22,31].  The conformation of the adsorbed protein is important in determining its 
bioactivity.  For example, enzymes often require a certain structure to maintain 
their activity.  If they unfold following adsorption this activity may be lost [32].  
Conversely, unfolding may expose cell binding epitopes that were originally 
buried within the protein when it was in its natured state [33-35].  In the case of 
blood compatibility, there is growing evidence that conformation is more 
important in determining the host response than the type or amount of protein 
adsorbed [34,36]. 
 
1.1.4 Plasma Proteins Relevant to Platelet-Biomaterial Interactions 
 
Human plasma contains numerous proteins with a variety of important 
physiological roles.  In the case of biomaterial-platelet interactions, plasma 
proteins such as albumin, fibrinogen, fibronectin, vitronectin, and von Willebrand 
factor (vWf) have all been studied in great detail.  Albumin makes up the largest 
percentage of blood proteins (~60%) [29]. Due to its high concentration in blood 
and relatively small size it is the first plasma protein to adsorb to a biomaterial 
after implantation.  However, over time, it is replaced with proteins with higher 
surface affinities such as fibrinogen [29].  For many years albumin has been 
believed to be relatively inert to platelet adhesion. Thus attempts have been 
made to design surfaces that either promote albumin adsorption [37,38] or are 
directly coated with albumin [39]. However, more recently, albumin has been 
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shown to support platelet adhesion and thus may not be completely inert [35].  It 
has been postulated that this may be due to the conformational exposure of 
binding epitopes for platelets.  Fibrinogen (cplasma = 3 mg/ml) has been 
extensively studied by blood compatibility researchers and is required for both 
platelet adhesion and aggregation. Platelet adhesion to biomaterials has been 
shown to be drastically reduced when fibrinogen is removed from plasma [40,41].  
Due to its central role in adhesion, preventing fibrinogen adsorption has been 
one approach used to develop more compatible biomaterials.  However, it is 
interesting to note that in its native state, fibrinogen is relatively inert to quiescent 
platelets; it is only when it is adsorbed and unfolds that adhesion is supported 
[42].  Once platelets are activated, fibrinogen is then able to support further 
adhesion and aggregation.  Although fibrinogen is the key protein that mediates 
platelet adhesion to biomaterials, vWf (cplasma = 10 µg/ml), has been shown to be 
critical in supporting platelet adhesion under flow conditions [43-46].   Vitronectin 
and fibronectin have also been shown to support platelet adhesion but are not 




Platelets are anuclear cell fragments derived from megakaryocytes in the 
bone marrow and play a crucial role in hemostasis (c ≈ 2∙108 platelets/ml). After 
vessel damage occurs, the coagulation cascade is initiated when tissue factor is 
released from the site of vascular endothelial injury [49].  Tissue factor initiates a 
series of enzymatic reactions that ultimately lead to the formation of thrombin 
[50].  Thrombin recruits and activates platelets which are involved in local 
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amplification of the coagulation cascade and clot formation.   Unfortunately, 
platelets also adhere and are activated by the adsorbed protein layer on 
biomaterials.  Thrombus formation on the surface of vascular implants can lead 
to occlusion of the device lumen, embolism, and inflammatory responses. To 
avoid these potentially life threatening complications, the ability to eliminate 
surface induced platelet activation has been a central goal of material 
hemocompatibility. 
 
1.2.1 Platelet Membrane Receptors 
 
The platelet membrane is rich in glycoprotein receptors embedded in the 
phospholipid bilayer which include tyrosine kinase receptors, integrins, leucine 
rich receptors, protein G coupled transmembrane receptors, selectins and 
immunoglobulin domain receptors.  These proteins are critical in transducing 
external signals into intracellular signaling events that mediate both cell-platelet 
and platelet-substrate interactions and are involved in haemostatic functions, 
inflammation, tumor growth and immunologic reactions. This section will review 
the two most abundant receptors on the platelet membrane, integrin αIIbβ3, and 
glycoprotein Ib-IX-V (GPIb-IX-V), which control platelet adhesion and activation 
processes.   
The most abundant receptor on the platelet membrane is the αIIbβ3 integrin 
receptor.  This receptor, unique to platelets, is a key mediator of adhesive and 
aggregation interactions [51]. The main ligand for αIIbβ3 is fibrinogen, [52,53] a 
dimeric protein with each monomer consisting of an α, β and γ-chain.  Three 
binding epitopes for αIIbβ3 exist in fibrinogen, two RGD motifs in the α-chains and 
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one dodecapeptide sequence in the γ-chain [54,55].  The importance of the RGD 
binding motifs in adhesion and aggregation has received some speculation 
[56,57] and may even be inhibitory, while the dodecapeptide γ sequence is 
believed to be critical [58].  Also, the possibility for other binding motifs to exist 
cannot be ruled out [51]. In quiescent platelets, αIIbβ3 exists in an inactive form 
and must be activated to bind soluble fibrinogen [59].  However, when fibrinogen 
is adsorbed, αIIbβ3 is capable of binding even in the absence of activation [60].  
Besides fibrinogen, vWF, fibronectin, thrombospondin and vitronectin can all bind 
to the αIIbβ3 complex [61,62].  Other integrins expressed on the platelet 
membrane include αIIβ1, αVβ1, and αVIβ1 that support platelet-vessel wall 
adhesive interactions to the ECM proteins collagen, fibronectin, and laminin, 
respectively [63-65]. However, detailed descriptions of these mechanisms are 
beyond the scope of this dissertation and can be reviewed elsewhere [61]. 
 GPIb-IX-V is a leucine rich transmembrane receptor formed by a 
multiprotein complex of four different glycoproteins.  This is the second most 
abundant receptor on the platelet membrane and is involved in the initial 
attachment of platelets to the vessel wall or a biomaterial under high shear 
conditions via the ligand vWf [43,66].  The interaction between vWf and GPIb-IX-
V is not as strong as the interaction between αIIbβ3 and fibrinogen; therefore, it is 
not believed to be sufficient in supporting irreversible adhesion [43]. Binding of 
vWf to GPIb–IX–V is also involved in transmitting intracellular activation signals, 
triggering degranulation, elevation of cytosolic Ca2+, cytoskeletal actin 
rearrangements, and “inside-out” activation of αIIbβ3 that binds vWf or fibrinogen 
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and mediates platelet aggregation [67,68]. Aside from platelet adhesion and 
activation, GPIb-IX-V can also bind both P-selectin expressed on endothelial 
cells and the integrin Mac-1 (integrin αMβ2) on leukocytes and consequentially 
may be involved in inflammatory interactions [69,70]. 
 
1.2.2 Mechanism of Platelet Adhesion 
 
Platelet adhesion is supported by specific interactions between membrane 
receptors and adsorbed plasma proteins.  The receptors GPIb-IX-V and integrin 
αIIbβ3 discussed in the previous section are the key adhesion receptors and 
interact with both vWf and fibrinogen respectively [53,66]  Specifically, the GPIb-
IX-V complex transiently binds to surface immobilized vWf to promote stable 
platelet adhesion.  This process referred to as “platelet tethering” acts to slow 
down platelets in flowing conditions. The bonds between vWf and GPIb-IX-V are 
relatively weak and reversible, but nonetheless facilitate stable αIIbβ3-fibrinogen 
binding which is a slower bond to form (Figure 1.2).  Thus fibrinogen and vWf 
work synergistically to promote stable platelet adhesion on both a damaged 
vessel and biomaterials [43,71].  It is commonly cited that the amount of 
adsorbed fibrinogen is an important determinant in the hemocompatibility of a 
biomaterial.  This is likely due to fibrinogen‟s ability to support irreversible 
adhesion.  Fibrinogen has also been shown to convert platelets to a procoagulant 
state [40] in which many activation events occur including the up regulation of 
αIIbβ3 receptor expression on the platelet membrane.  Other plasma proteins 
such as collagen, fibronectin, and vitronectin have also been shown to support 









Figure 1.2 The mechanism of platelet adhesion: stable adhesion involves 
synergistic interactions between immobilized vWf and fibrinogen.  vWf is involved 
in the initial arrest of flowing platelets. This interaction is weak and reversible but 
















1.2.3 Platelet Activation 
  
 A variety of stimuli are capable of activating platelets. Platelets become 
activated when they interact with matrix proteins, such as collagen, at the site of 
vascular injury.  Platelets are also activated by adsorbed proteins on synthetic 
materials and are the first cells to adhere to the biomaterial surface [73].  
Platelets also become activated by agonists such as ADP released by platelets 
themselves, thromboxane A2 from inflammatory cells and thrombin generated by 
the coagulation response [74]. 
Platelet activation is a crucial step in thrombus formation and is 
characterized by a series of overlapping events which include morphological 
changes, membrane receptor expression/activation, release of procoagulant 
factors, and the translocation of negatively charged phospholipids from the inner 
to the outer face of the lipid bilayer [75].   In their quiescent state, the αIIbβ3 
integrin is unable to bind soluble ligands [59]. However, it is capable of 
interacting with immobilized fibrinogen and vWf present on the surface of 
implanted biomaterials [60].  Binding to these ligands triggers an outside-in 
signaling cascade that converts αIIbβ3 to its active conformation and initiates 
spreading [76,77].  When platelets initially adhere to a surface they convert from 
a discoid to a spherical morphology.  Interactions between αIIbβ3 and GPIb-V-IX 
with adsorbed adhesion proteins initiate phosphorylation dependent cytoskeletal 
rearrangements characterized by the extension of filopods from the adhered 
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platelet.  These filopods become more extensive as more specific adhesive 
contacts with the substrate are established.  This is followed by spreading which 
occurs by the growth of lamellipods that coalesce to form circular lamellae 
(Figure 1.3).  These conformational changes also lead to an inside-out 
conformational change in integrin αIIbβ3 that facilitates platelet aggregate 
formation. 
Platelets contain secretory organelles called α-granules, dense granules, 
and lysosomes that undergo release reactions called “degranulation” when 
platelets are activated.  In this process of exocytosis, many coagulation factors 
including adhesive proteins, growth factors, hydrolytic enzymes, and other 
coagulation stimuli are released [78]. The morphological changes described 
previously allow for the centralization of granules that subsequently secrete 
procoagulant factors and stimulate further activation and thrombus formation 
[79].  It has been observed that secretion events occur more frequently when 
platelets are in their fully spread state [80].  Also, during this process, αIIbβ3 
integrins and P-selectin are translocated from the α-granule membrane to the 
platelet membrane [81,75] where they are capable of supporting homotypic and 
heterotypic cell aggregation.  These receptors also act as a catalytic surface for 
coagulation and inflammatory reactions. 
 
1.2.4 Hemodynamic Considerations 
 
The rheological environment of the vasculature is an important modulator 




Figure 1.3 Differential interference contrast images of the spreading platelet. 
28 
 
activation and aggregation. However, as the velocity increases, the time 
membrane receptors have to contact immobilized ligands decreases thus 
lowering the efficiency of platelet recruitment to the substrate. Only the 
interaction between platelets and vWf is fast enough to initiate adhesion in high 
shear conditions [43].  Thus, elevated shear forces promote the initial binding of 
vWf by activating the GPIb-IX-V receptor [44]. This interaction induces 
intracellular signaling cascades characterized by Ca2+ mobilization [82,45], 
cytoskeletal rearrangements [83], protein kinase expression [84], and integrin 
αIIbβ3 expression/activation [67,82].  This is coupled with the release of soluble 
vWf from the platelet α-granules. Fibrinogen along with vWf then work 
synergistically to form stable adhesive contacts [43,68,71]. 
In the vasculature, cells are exposed to hydrodynamic induced pressure, 
strain and shear forces.  Shear stress results in a force per unit area on the cell 
which can damage platelets at high flows [85].  Platelet lysis results in the 
release of procoagulant factors and subsequent activation of surrounding 
platelets.  The extent of mechanical damage to platelets is related to both the 
magnitude and the duration of exposure [85,86]. 
 
1.2.5 Platelet-Material Interactions: A Central 
Issue in Hemocompatibility Research  
 
Due to the central role of platelets in thrombus formation and coagulation, 
platelet adhesion often serves as a key criterion in material hemocompatibility 
testing. Many approaches in designing platelet-inert materials have been 
explored.  Efforts to reduce platelet adhesion and activation commonly follow one 
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of three approaches: 1) endothelialization, 2) surface modification, and 3) 
bioactive coatings. 
The only truly blood compatible surface, known to prevent platelet 
activation, is an intact and functional endothelial cell (EC) monolayer. ECs make 
up the innermost lining of blood vessels and possess many anti thrombotic 
properties.  Naturally, researchers have sought to improve vascular device 
compatibility by seeding viable ECs on the device surface prior to implantation 
[87-89]. The process to achieve successful endothelialization is complex and 
currently there exists no method that can be used in a clinical setting. This 
process requires an autologous source of cells that must be isolated and 
expanded prior to seeding.  Issues with contamination and dedifferentiation are 
also problematic [89]. Furthermore, after seeding, the confluent EC monolayer 
must be preconditioned under a dynamic flow environment that mimics the 
natural vasculature. Often, in transition from in vitro to in vivo conditions, ECs are 
lost due to handling and reperfusion injury.  However, when done successfully, 
this modification has resulted in lower overall platelet adhesion in vitro as well as 
some animal studies.  Unfortunately, this technique is expensive and slow, not 
allowing for its use in emergency situations [90].   As an alternative, researchers 
have sought to promote EC proliferation on implants post implantation by 
precoating the surface with extracellular matrix proteins that promote EC 
adhesion and migration. However, these proteins (i.e., fibronectin and collagen) 
are also thrombogenic and increase complications such as embolism [91].  For 
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these reasons, it is unlikely endothelialization will see any practical applications 
in the near future despite promising in vitro results.  
To try and mimic the natural vessel, bio-inspired surface modifications 
have been explored.  ECs continuously produce and release nitric oxide (NO) 
from the vessel wall and NO is known to inhibit platelet adhesion and activation 
[92].  As a result, polymers doped or grafted with NO donors been explored to 
reduce platelet adhesion and activation to biomaterials [93,94].  However the 
development of polymers capable of long term consistent NO release has been 
challenging [95].  The geometry of the EC monolayer has also been 
hypothesized to play a role in its anti-coagulant properties.  Fan et al. 
demonstrated that platelet adhesion could be reduced on surfaces that were 
fabricated to be geometrically similar to the lining of vessels which may be a 
result of low collision frequencies on such geometries [96].  Unfortunately, some 
adhesion/activation still occurred suggesting that thrombus formation is still 
possible in time.  Also, there is no information on complement, immune, and 
coagulation responses to these surfaces. Biomembrane mimetic vascular 
biomaterials have been prepared by surface immobilization of phosphorylcholine 
chemical groups and other phospholipids [97-99]. Both techniques have been 
shown to minimize protein adsorption and platelet adhesion.  It is hypothesized 
that this phenomenon may be due to the zwitterionic nature of these surfaces 
and their ability to maintain a stable hydration layer. Again, however, in vivo 
studies have produced conflicting results on the efficacy of these materials in 
reducing thrombosis [98,99].   
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Given that cell and platelet adhesion is mediated by plasma proteins, 
surface modification techniques aimed at minimizing protein adsorption have also 
been explored.  Both natural and synthetic molecules have been investigated as 
potential protein resistant coatings.  Carbon coatings including pyrolytic carbon 
and diamond-like carbon have raised much interest as potential wear resistant 
coatings for biomedical applications due to their attractive properties such as 
high hardness, high chemical inertness, and low friction coefficient [100-102].  
However, the ability of these coatings to improve the blood response to synthetic 
vascular devices is still inconsistent.  In fact, a recent study explored the 
thrombogenicity of carbon coated grafts compared to controls and showed no 
significant difference in long term compatibility [103]. 
As discussed in section 1.1.4, the plasma protein albumin is believed to be 
relatively inert to platelets [38].  Subsequently, researchers have sought to 
passivate biomaterials either by precoating them with albumin or by tailoring the 
surface to favor albumin adsorption [37,38,104].  Although albumin coated 
surfaces demonstrate improved biocompatibility, improvements in long term 
patency have been limited when compared to controls [105].  This may be due to 
the eventual denaturation or displacement of albumin by plasma proteins with a 
higher surface affinity in vivo. 
Polyethylene glycol (PEG) has been immobilized to various biopolymers 
and been shown to be very effective in minimizing protein adsorption and platelet 
adhesion [106,100,107,108]. This is hypothesized to be due, in part, to its low 
interfacial free energy and solubility of these polymer chains in water [107]. Also 
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PEG chains may have a steric stabilization effect in which protein adsorption 
results in a loss of configurational entropy.  Regrettably, developing strategies to 
firmly attach PEG to biomaterials has been troublesome and coatings still do not 
possess long term stability in biological fluids [109].  Also, only a few in vivo 
studies have been conducted and long term results are inconsistent [99,110].  
Another approach involves using bioactive coatings that function to inhibit 
thrombin generation [111].  Specifically, compounds such as heparin [112-114] 
and thrombomodulin [115] have been grafted to biomaterials and have been 
demonstrated to reduce platelet adhesion in vitro.  Commercially available 
heparinized devices, including the PROPATEN vascular graft (W.L. Gore & 
Associates, Inc. Flagstaff, Arizona), have also demonstrated promising in vivo 
results [113]. However, their success in long term applications such as vascular 
access for hemodialysis patients has been limited [114]. It is important to note 
that immobilization of these compounds may result in an overall loss of activity.  
Also, once implanted, their preservation on the surface is limited due to the harsh 
physiological environment.  
Despite extensive efforts to minimize platelet adhesion and activation the 
development of a truly biocompatible material has yet to be realized.  As 
discussed above, numerous studies have demonstrated materials capable of 
reducing platelet adhesion and activation; however, translation of these materials 
to clinical practice is almost completely stagnant.  This is likely due to the fact 
that the mechanisms of blood activation are tremendously complex, and these 
strategies alone still cannot completely eliminate an adverse response.  Our 
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understanding of the mechanisms behind these processes is still incomplete, 
making in depth fundamental studies of platelet adhesion/activation a critical 
precursor to the development of hemocompatible materials. 
 
1.3 Surface Patterning and Biological Applications 
 
The fate of a synthetic biomaterial after implantation is largely determined 
by the properties of its surface.  As discussed in previous sections, the surface 
characteristics determine the nature of the adsorbed protein layer which 
subsequently directs the cellular response.  Consequently, a significant amount 
of work has been devoted to studying cause effect-relationships between cells 
and their substrate.  Surface patterning is one tool that allows for the precise 
geometric control of both the physical and physiochemical composition of the 
substrate.  Novel patterning techniques have been implemented to design 
surfaces with variations in properties, such as topography, charge, 
hydrophobicity, and the spatial orientation of ligands, such as proteins and 
synthetic peptides [108,117-122].  The patterning of chemical gradients has been 
used as a high throughput method to rapidly screen protein and cell surface 
interactions over a variety of conditions [24,123-131].  If a particular surface 
property is found to have a desired response, it can be exploited for the given 
application. Patterned substrates have also been developed to contain spatially 
defined domains presenting biomolecules surrounded by an inert background.  
These surfaces have been extremely valuable in the development of 
protein/oligonucleotide arrays, biosensors, and cell-based arrays [132].   They 
have also been useful for fundamental studies of cellular processes including 
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adhesion, migration, proliferation and apoptosis [120, 133-136].  Even surfaces 
patterned with specific mixed hydrophilic/hydrophobic chemistries resist the 
attachment of marine organisms and have been explored as a potential solution 
for biofouling of ships and other marine structures [137].  Hence, surface 
patterning techniques have proven to be a valuable tool used for a wide variety of 
applications.   
This section will review two types of surface patterning techniques: 
photolithography and soft lithography, and their applications in studying platelet-
substrate interactions. 
 
1.3.1 Photolithography  
 
Photolithography has been used widely for surface patterning applications 
in the biomedical field.  Generally, this technique first involves the deposition of a 
photosensitive polymer onto a surface.  The sample is then selectively exposed 
to ultraviolet light through a mask possessing the desired surface pattern.  Only 
the exposed areas polymerize.  Nonpolymerized regions can be washed away 
with a solvent leaving only the desired pattern (Figure 1.4).  
Photolithography can be used to pattern well defined microfluidic networks 
that allow for a high throughput experimental design while minimizing the 
required sample size, a particularly valuable asset in biological studies [138]. 
Using a similar concept, thermo responsive polymers, such as poly(N-
isopropylacrylamide), can be removed by selective UV light exposure. 
Photoablation of this polymer has been used to control patterns of cell growth 



















sensitive to photolysis, have been coupled to polysaccharides and used to 
pattern molecules such as hylauronic acid [141] and heparin [123] on surfaces.   
Photolithography can also be applied to generate patterns of different 
surface chemistries [142].  For example, Bhatia et al. designed surfaces by 
selectively exposing thiol monolayers to UV light.  Exposed regions oxidized to 
sulfonate groups and demonstrated good resistance to protein adsorption.  
Proteins were covalently immobilized  to  the  unoxidized  thiol regions  allowing 
for well defined  protein  surface 
patterns to be designed [122,143]. Photolithography continues to be a popular 
tool due to its ability to provide excellent control and reproducibility over the 
surface patterns. However, it is not compatible with compounds that are sensitive 
to UV light energy or etchants, such as certain biological agents.  Also, this 
technique is dependent solely on UV light exposure and can only be used to 
fabricate binary surface patterns; thus, a more robust patterning technique is 
needed. 
 
1.3.2 Soft Lithography 
 
 Soft lithography is a technique in which flexible elastomeric stamps are 
used to fabricate surface structures or patterns and possesses many advantages 
over standard photolithography techniques.  Soft lithography is less expensive 
[144], more robust, does not require the use of photosensitive substrates, and 
can be applied to the patterning of nonpolar surfaces, all important features for 
many biological applications [145].  First, the elastomer stamp is prepared by 
cast molding in a mask or template.  Masks are prepared by a variety of 
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techniques including photolithography, micromachining and e-beam writing. 
Polydimethylsiloxane (PDMS) is often used for stamp fabrication due to its low 
interfacial energy, dimensional shape fidelity and thermal stability. However, 
other polymers such as polyurethanes and polyimides have also been explored 
[145].  After the elastomer is poured over the mask, the polymer is cured and 
carefully peeled off the template.  These stamps can be used to pattern surfaces 
in a variety of ways, including microcontact printing, microtransfer molding, 
replica molding, soft embossing, and micromolding in capillaries.  Schematics of 
these processes are presented in Figure 1.5 and can be reviewed elsewhere 
[145-148].  Here, the review will focus on microcontact printing since it is the 
primary patterning technique used for the studies in this dissertation. 
Microcontact printing (µCP) is a soft lithography technique in which a 
patterned elastomeric stamp is used to directly transfer an „inked‟ material onto a 
substrate (Figure 1.5a) and allows for the precise deposition of inked surface 
ligands (i.e., proteins/peptides) with excellent control over amount, size and 
position. Micro contact printing has proven to be a useful technique for surface 
functionalization and has been particularly valuable in the patterning of biological 
materials [135].  Originally, µCP was used as a method to pattern gold [149]; 
however, its value in patterning surfaces for other applications quickly became 
obvious [119,150]. Microcontact printing has been used to study many different 
cellular phenomena including adhesion, migration, and apoptosis [118,120,133].  
This technique has even been used to engineer the surface of human tissue 






Figure 1.5 Schematic representations of soft lithography techniques: (A) 
microcontact printing, (B) microtransfer molding, (C) soft embossing, and (D) 






























molecules to control the growth pattern of epithelial cells on the substrate [151]. 
 
 
1.3.3 Surface Patterning and Applications in Platelet-Material Studies 
 
The platelet membrane is covered with membrane receptors. Interactions 
between platelet receptors and immobilized ligands are central to adhesion, 
activation and aggregation mechanisms.  Also, platelet morphology plays a 
critical role in activation processes.  Thus there is inherent value in the use of 
surface patterning techniques to study both fundamental platelet adhesion 
mechanisms as well as biomaterial-induced platelet responses.   
The preparation of surface chemistry gradients is one patterning technique 
widely used to study both protein adsorption and platelet adhesion phenomena.  
Chemical gradients have been prepared using photolithographic techniques and 
provide a combinatorial advantage over homogeneous test samples. Lee et al. 
first used surface gradients in platelet adhesion assays.  Samples were prepared 
by treating polystyrene surfaces with varying levels of corona discharge resulting 
in a gradient of reactive functional groups on the substrate [124].  PEG molecules 
of varying chain lengths were immobilized to these substrates and used to 
quantify protein adsorption and platelet adhesion [108]. Gradients prepared to 
have varying wettabilities and charges have also been used in platelet adhesion 
studies [121,125]. 
Applications of μCP for platelet adhesion assays have also been explored. 
Basabe-Desmonts et al. used this technique to immobilize fibrinogen, vWf and 
CD42b antibodies to glass substrates and then subsequently capture platelets 
from whole blood.  This technique allows for quantification of adhesion, 
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morphology changes, and platelet receptor expression potentially improving 
platelet adhesion and functionality studies [152].  
Ekblad et al. recently patterned protein resistant PEG based hydrogels 
onto polystyrene surfaces using standard photolithography techniques to graft 
the polymer to the surface.  After incubation with fibrinogen, excellent control 
over platelet adhesion was observed.  Furthermore, the hydrogel was 
functionalized with reactive NHS ester groups for protein covalent immobilization.  
The surface was then selectively incubated with both anti-GPIb and fibrinogen 
using microfluidic patterning techniques.  Platelet adhesion was observed on 
both protein substrates suggesting that protein covalent immobilization to the 
hydrogel results in platelet reactive subsrates [153].  Microfluidic patterning of 
proteins has also been used by Kastrup et al. to study coagulation.  Specifically, 
they patterned surfaces with different sized dots of the coagulation stimuli, tissue 
factor. They were able to show that the initiation of clot formation depends on a 
threshold size as well as spacing between the dots suggesting roles for both 
amount and diffusion in initiating a clotting response [154]. 
Surface patterning techniques provide researchers simplified physical or 
chemical model systems.  These are attractive for understanding biological 
complexity because these models can be made simple to probe, analyze, and 
understand specific variables in a well controlled environment.  Well-defined 
surface patterns have been applied to many studies of basic cellular processes 
such as geometrically controlled apoptosis [134] and cell adhesion/migration 
[118,120,133,155].  However, the application of surface patterning to studying 
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fundamental platelet phenomena is still relatively new.  In this dissertation, 
photolithography prepared chemical gradients and µCP patterning techniques 
were used to explore both fundamental and biomaterial-induced platelet 
adhesion and activation mechanisms. 
 
1.4 Dissertation Overview 
 
 The central goal of the work described in this dissertation was to develop 
well defined microenvironments to uncover fundamental cause/effect 
relationships related to surface induced platelet responses.  Specifically, 
molecular patterning techniques were used to control both the chemistry and 
immobilized protein content of the surface.   In Chapter 1, molecular charge 
gradients were used to screen the platelet response over a variety of chemistries 
with varying preadsorbed protein layers.  In this study, it was observed that 
upstream platelet interactions with the surface may affect downstream adhesion.  
The potential ability of platelets to be “primed” for downstream adhesion and 
activation was further characterized in Chapter 2.  In this study, the position of 
fibrinogen “priming” regions was controlled using μCP.  The platelet response in 
downstream “capture” regions (also prepared using μCP) was evaluated and 
compared with samples that do not contain a “priming” region.  In Chapter 3, the 
use of μCP was explored further as a means to directly control platelet adhesion 
and morphology.  The ability to control the adhesive and morphological platelet 
response will be valuable in designing future studies aimed to directly link these 




1.4.1 Screening Platelet-Surface Interactions Using Negative  
Surface Charge Density Gradients 
 
The selection of biomaterials for vascular devices requires consideration 
of both their bulk and surface properties.  Polymeric and metallic materials such 
as polyurethane, polytetrafluoroethylene, and stainless steel are often chosen for 
their favorable mechanical and processing properties.  Unfortunately, the 
surfaces of these materials are often thrombogenic, leading to platelet activation 
and thrombus formation. As discussed in section 1.2.5, surface modification is a 
popular method used to improve the platelet response to biomaterials without 
altering its bulk properties.  Many surface modification techniques have been 
attempted with some success [100,156-161]. However, a truly blood compatible 
interface has yet to be realized.  This is primarily due to the complexity behind 
surface-induced protein and platelet interactions and the virtually infinite number 
of surface modification techniques that can be considered. 
 Molecular gradients provide a combinatorial advantage to screen surface 
induced protein and platelet interactions over a variety of chemistries 
[125,126,162]. This tool is also capable of providing insight on potential 
synergistic phenomena that may occur in regions of mixed properties.  In 
Chapter 2 of this dissertation a versatile negative charge density gradient based 
on selective oxidation of a thiol monolayer was developed.  Gradients were 
preadsorbed with three protein solutions (human fibrinogen, albumin, or plasma) 
and platelets were perfused over the sample in a parallel plate flow chamber.  
Adhesion patterns were found to be affected by the type and concentration of the 
preadsorbed plasma as well as the negative charge density.  Interestingly, 
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adhesion patterns were also affected by the orientation of the gradient samples 
suggesting that the history of transient upstream platelet-surface interactions can 
affect downstream results.  
  Traditionally, blood compatibility studies focus on establishing the local 
platelet response to the biomaterial.  However, since platelet adhesion and 
activation is often transient, these studies are not sufficient to understand the 
whole story [163] and have serious implications for the design of in vitro studies 
using molecular gradients.  Also, characterizing the effect of upstream platelet-
agonist interactions on the downstream response is crucial in understanding 
biomaterial-induced platelet adhesion, activation and aggregation. 
 
1.4.2 Effect of Upstream Platelet-Agonist Interactions on  
Downstream Adhesion and Activation 
 
The region where a vascular device joins native vessel, known as the 
anastomosis, is characterized by high rates of stenosis (narrowing) and 
subsequently, higher fluid shear rates [100].  The anastomosis is also 
characterized by adsorption of fibrinogen and the exposure of collagen due 
damage of the vessel endothelium at this location [107].  This presents an ideal 
environment for platelet activation to occur and may have serious consequences 
for the blood compatibility of the downstream biomaterial.  Also, in vitro studies 
only focused on local platelet-material interactions do not account for activation 
that does not result in an adhesion event.  For example, upstream platelet 
activation on devices such as prosthetic heart valves and stents, may cause 
downstream thromboembolic complications [5,86]. Also, the most common cause 
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of arteriovenous graft failure in hemodyalisis patients is neointimal hyperplasia at 
the graft-venous anastomoses [164,165].  The exact mechanism is not yet 
understood, however, it has been suggested that the physiology of the venous 
endothelial layer may play a role [165].  It is possible however, that the upstream 
artery-graft anastomoses may be preactivating platelets for downstream 
adhesion since this region is characterized by both high shear forces as well as a 
damaged endothelial layer.  To better understand the role of platelet activation in 
device failure we must take into account the transient nature of adhesion and 
activation.   
In Chapter 3 of this dissertation, the effect of upstream platelet-fibrinogen 
interactions on downstream adhesion, activation and aggregation was 
characterized.  Test samples were prepared by covalently immobilizing an 
upstream platelet “priming” region and a downstream capture region using 
microcontact printing of fibrinogen.  The activation state of platelets that did not 
adhere was also considered by quantifying expression levels of P-selectin, and 
the active form of integrin αIIbβ3 using flow cytometry.  It was discovered that the 
presence of surface-immobilized upstream fibrinogen did in fact result in an 
increase in downstream adhesion, activation and aggregation when compared 
with controls.  This effect was attenuated when the upstream priming region was 
blocked with a polyclonal antibody for fibrinogen further confirming its role in 







1.4.3 Well-Defined Protein Micropatterns for Platelet Adhesion 
and Activation Studies Using Microcontact Protein Printing 
 
As discussed in section 1.3, protein patterning has been widely applied to 
in vitro studies of cellular mechanisms. However its use in fundamental platelet 
adhesion and activation studies is relatively unexplored.  In Chapter 4, well 
characterized random fibrinogen micropatterns with 20%, 50% and 85% surface 
coverage areas were prepared using microcontact printing.  It was discovered 
that both platelet adhesion and activation could be titrated by varying the relative 
surface coverage of fibrinogen. Varying the surface ligand coverage also resulted 
in different feature shapes and sizes which were capable of controlling platelet 
morphological characteristics.  The ability to precisely control the amount and 
distribution of immobilized platelet ligands will be valuable in establishing direct 
cause-effect relationships between platelet-surface interactions and adhesion 





SCREENING PLATELET-SURFACE INTERACTIONS USING  
 




When a vascular device is implanted a host of responses occur at the 
blood-material interface including protein adsorption and platelet activation. 
Surface properties such as charge, roughness, and hydrophobicity all play critical 
roles in determining both the protein and platelet response and subsequently, the 
material's blood-compatibility. A popular approach to the development of 
hemocompatible materials is to try and tailor the properties of the surface such 
that it is inert to platelet activation [106,156,157].  However, surface properties 
can be varied in an unlimited number of ways and the plasma protein and platelet 
responses can be complex and difficult to elucidate. Surface chemistry gradients 
provide a more rapid approach to screen blood-material interactions over a 
variety of surface properties. They are also valuable in providing insight on 
potential synergistic phenomena that may occur in regions of mixed properties 
[126]. Molecular gradients have been used to study many different types of 
biological phenomena including both protein adsorption [127,128,169] and cell 
and platelet adhesion [129, 170].  Specifically, gradients have been used to study 
the effects of variables such as wettabillity, charge, and polymer chain length on 
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platelet adhesion [121,125,162,130]. The inherent value of using surface 
gradients lies in the ability to identify local effects over a variety of chemistries in 
a single experiment. However, the reproducibility of local effects once the 
homogeneous surface is prepared as well as the effect of gradient orientation 
have not been well documented. 
The work included in this chapter describes a versatile method to produce 
one-dimensional negative surface charge density gradients. The design was 
based on the selective oxidation of a uniform thiol monolayer to negatively 
charged sulfonate groups by UV irradiation [171].  Platelets were perfused over 
the samples and adhesion patterns on the gradient surfaces was measured and 
compared with uniform thiol monolayer control surfaces. Three protein solutions 
(platelet free plasma, fibrinogen and albumin) were preadsorbed onto the 
gradient and control samples to study the role of adsorbed proteins in platelet 
adhesion. Also the extent to which gradients provide information on local surface 






2.2.1 Preparation of Thiol Monolayers 
 
Negative surface charge gradients were prepared by selective oxidation of 
thiol monolayers on 3” fused silica (FS) slides. Before surface modification, FS 
slides had to be rigorously cleaned using a four-step cleaning procedure. First 
the FS slides were cleaned in an oxidizing acid bath overnight. On the following 
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day, the samples were dried with N2 gas and then placed in a 10 minute oxygen 
plasma treatment (Plasmod, Tegal Inc., 50W @ 200mTorr). The FS slides were 
then incubated in a 7:3 H2SO4-H2O2 (“piranha”) solution for 1 hour. This was 
followed by a final 10 minute oxygen plasma treatment to activate the surface 
prior to the reaction. To prepare the thiol monolayer, clean FS slides were 
incubated in a 1% v/v solution of 3-mercaptopropyltrimethoxysilane (MTS, United 
Chemical Technologies) in toluene for 4 hours (Figure 2.1). FS slides were rinsed 
in sequence using solutions of increasing hydrophilicity (toluene, acetone, 
ethanol, and water) and dried with N2 gas. The samples were stored under 
vacuum until use and were not kept for longer than one week. 
 
2.2.2 Preparation of Negative Charge Density Gradients 
 
A gradient of surface charge was achieved by selectively exposing thiol 
monolayers to UV light (ELC-4000, Electrolite Corp.) in a custom designed 
patterning chamber (Figure 2.2). The physical length of the gradient as well as 
the extent of the thiol to sulfonate conversion was controlled by linear translation 
of an edge mask over the center of the sample. For these studies, the translator 
moved the edge mask at a constant rate of 0.25 cm/min across center of the 
slide for four minutes, creating a 1 cm long oxidation gradient in the center of the 
slide. As a consequence of UV oxidation the surface thiol (-SH) group is oxidized 
into a sulfonate (-SO3
-) group thus creating a 1-D variation of surface charge, 
from fully ionized sulfonate to weakly ionized thiol groups.  Furthermore, the 











Figure 2.1 Fused silica silanization reaction scheme: thiol monolayers were prepared by 
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Figure 2.2 Preparation of the surface charge density gradient is accomplished by 
translating the edge mask at a constant rate over a 1 cm region of the uniformly 
modified MTS silica slide. On the UV exposed region the surface thiol group is oxidized 










utilized for a second chemical reaction thus making the MTS + UV oxidation 
method a versatile basis for several different surface chemistry gradients [172]. 
 
 2.2.3 Gradient Characterization 
 
Water contact angle measurements are an easy way to detect the 
wettability changes of the thiol to sulfonate gradients. Prior to each experiment, 
receding water contact angles were measured by the sessile drop method using 
a contact angle instrument (CAM 100, KSV Instruments). Equal 5 μl purified 
water droplets were dispensed along the length of the sample and water contact 
angle was plotted as a function of position on the FS slide. The extent of the thiol 
to sulfonate conversion was also verified using high resolutions ESCA spectra of 
S2p peaks. The XPS spectra of MTS-modified silica and UV oxidized MTS 
modified silica was recorded with a XPS spectrometer (Axis-Ultra DLD, Kratos) at 
the University of Utah Nanofab Lab. 
 
2.2.4 Protein Solution and Washed Platelet Preparation 
 
Three different human protein solutions were prepared: platelet free 
plasma, fibrinogen (plasminogen free, Calbiochem) and albumin (Fraction V, 
Sigma) in phosphate buffered saline (PBS). Platelet free plasma was obtained by 
filtration of the platelet poor plasma (PPP) collected during the washed platelet 
preparation using 0.22 μm low protein binding filters (Millipore). For the studies 
involving testing the effect of PFP concentration on platelet adhesion the PFP 
concentration was adjusted using PBS (pH 7.4) to 1%, 10% or 50% of normal 
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physiological PFP concentration. Fibrinogen and albumin solutions were 
prepared in PBS at 10% of each protein’s normal physiological concentration.  
Washed platelets were prepared from whole blood from healthy human 
donors. Blood was collected in a 1:7 anticoagulant citrate dextrose (ACD) 
solution and centrifuged for 15 minutes at 1500 rpm to separate platelet rich 
plasma (PRP) from the red blood cells. The PRP supernatant was aspirated off 
using a transfer pipette. Prostaglandin E1 (PGE1, 300 nM) was added to the PRP 
to inhibit aggregation during preparation [173]. PRP was centrifuged for 15 
minutes at 2100 rpm for platelet isolation. The PPP supernatant was carefully 
transferred to a clean polypropylene test tube, not disturbing the platelet pellet. 
The platelet pellet was gently resuspended in prewarmed Tyrode’s-HEPES buffer 
(37 ⁰C, pH 7.4) [174] and 300 nM PGE1. Platelets were counted using a 
hemocytometer and the concentration was adjusted to 1.5•107 platelets/ml. 
 
2.2.5 Platelet Adhesion Studies  
 
All protein and washed platelet solutions were maintained at 37⁰C 
throughout the experiments. A syringe pump (Kent Scientific) was used to draw 
solutions through a parallel plate flow chamber (length 7 cm, width 0.5 cm, 
thickness 0.05 cm) at a constant flow rate (40 ml/hr) thus creating a shear rate of 
92 s-1. The flow cell was connected to the solutions using 15 cm long 
polyethylene tubing (shear rate of 24 s-1) (Figure 2.3). A three step perfusion 
process was used to study platelet adhesion. First a protein solution was 
perfused through the flow cell for 15 minutes to allow for plasma protein 






















minute perfusion of a washed platelet suspension avoiding any surface-air 
contact. The washed platelet suspension was diluted to 107 platelets/ml and 
activated by adding Ca2+  (2 mM) and ADP (1 μM) to the solution prior to 
perfusion. 
The platelet perfusion time of 5 minutes was selected to minimize the 
formation of platelet aggregates which may be more indicative of platelet-platelet 
interactions than of interactions with the protein covered gradient surface. In the 
final step a 1% glutaraldehyde solution was injected into the chamber for 15 
minutes to fix the sample. All unbound platelets were washed from the sample 
with PBS prior to counting. 
The platelets adhered to the surfaces were visualized using differential 
interference contrast microscopy (DIC, Diaphot 300, Nikon). Separate counts (n 
= 10) for 20 positions at 1 mm increments including the gradient region were 
taken and converted to the number of platelets per mm2. To account for variable 
platelet activity over different donors, all data were normalized using a uniform 
thiol sample (i.e., MTS modified silica with no gradient) preadsorbed with 10% 
PFP as a baseline. Adhesion contrast on gradient samples was determined to be 
significant by performing an unpaired t-test comparing adhered platelets found in 
the sulfonate and the thiol regions (n = 20). 
 
2.3 Results and Discussion 
 
2.3.1 Surface Characterization  
 
Receding water contact angles between 50⁰-55⁰ were measured in the 
thiol region of the sample and between 8⁰-12⁰ in the sulfonate region (Figure 
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2.4a). Water contact angles decreased through the region exposed to variable 
UV irradiation times indicating the presence of a gradient in the center of the 
sample. The XPS S2p spectra of the MTS-modified silica and 4 minutes UV 
oxidized MTS-modified silica are shown in Figure 2.4b. The elemental XPS 
analysis showed ~2 atomic % of sulfur, an expected value for an MTS monolayer 
[172]. For MTS-modified silica (dashed line, Figure 2.4b) a strong S2p peak at 
163.5 eV confirmed the presence of surface thiols. After 4 minutes of UV 
irradiation (full line, Figure 2.4b), the 163.5 eV peak decreased in magnitude 
while the peak at 168 eV increased. The higher binding energy peak indicated 
that the sulfur atoms from the –SH groups has combined with oxygen, forming a 
sulfonate moiety [171]. The conversion of thiol to sulfonate was incomplete: the 
fraction of sulfur in the oxidized state was around 0.6. Also, a small fraction of 
oxidized thiols was present on the MTS-modified silica which was not irradiated 
by UV, possibly due to spontaneous oxidation of thiols in air. 
 
2.3.2 Effect of PFP Concentration and Platelet Adhesion 
 
Blood plasma concentration has been noted to influence the composition 
of the adsorbed protein layer as well as subsequent platelet-surface interactions 
[175,176].  In this study, sulfonate-to-thiol gradient surfaces were preadsorbed 
with three different PFP concentrations (1%, 10%, and 50% of physiological PFP 
concentration). Average platelet adhesion (n = 10) was quantified over a 20 mm 
region of the sample, including the gradient region, at 1 mm intervals with the 
gradient located between 5 mm and 15 mm (Figure 2.5a). The error bars 




Figure 2.4 Characterization of negative charge density gradients: (A) Receding 
water contact angles plotted as a function of distance from the negatively 
charged sulfonate end of the gradient sample. (B) High resolution XPS S2p 
spectra of the MTS-modified silica control (dashed line) and 4 minutes UV 
oxidized MTS-modified silica (full line). 
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corresponding to a decrease in negative charge density was observed for all 
three PFP concentrations. An unpaired t-test comparing the sulfonate region with 
the thiol region was performed for all three concentrations and shown to be 
significantly different with a confidence interval of p < 0.0001, n = 20. Samples 
preadsorbed with 1% and 50% PFP showed less adhesion contrast across the 
gradient region compared to samples preadsorbed with 10% PFP.  Brash et al. 
have reported that the amount of adsorbed fibrinogen on glass is dependent on 
plasma concentration while albumin is not [175]. Thus, one possible explanation 
for less adhesion contrast at 1% dilutions is that the ratio of adsorbed fibrinogen 
to adsorbed albumin is not enough to support extensive platelet adhesion. In 
other words, the overall fibrinogen concentration may not be sufficient to out 
compete albumin and override its inhibitory effect.  
A higher number of platelet aggregates was observed on gradient 
samples preadsorbed with 50% PFP compared to 1% and 10% PFP (Figure 
2.5b). The increase in aggregate formation may be more representative of 
platelet-platelet rather than platelet-surface interactions. Gradient surfaces 
preadsorbed with 10% PFP provided the best adhesion contrast and therefore 
this concentration was used for the remaining platelet adhesion experiments.   
 
2.3.3 Platelet Adhesion on Gradient Surfaces 
 
Platelet adhesion on sulfonate-to-thiol gradient surfaces preadsorbed with 
three different 10% protein solutions (PFP, fibrinogen, and albumin) is shown in 
Figure 2.6. The platelet suspension was perfused in the sulfonate to thiol 




Figure 2.5 Effect of PFP concentration on platelet adhesion to gradient surfaces: 
(A) Average number of adhered platelets were measured.  For every position the 
adhesion values represent a mean value where n = 20. Positions 0 – 5 mm 
represent the sulfonate region and 15 - 20 mm the thiol region with the gradient 
region between 5 mm – 15 mm. The platelet suspension was perfused in the 
direction from the sulfonate region, over the gradient, to the thiol region. (B) DIC 
images of platelet adhesion on sulfonate and thiol regions for 1%, 10%, and 50% 





















20 mm region covering approximately 5 mm on each side of the gradient at 1 mm 
intervals (n = 10) with the gradient located between 5 mm – 15 mm. The 
normalized platelet count for each position is plotted as a function of distance 
with the error bars representing the standard deviation of each sample. Uniform 
thiol surface (i.e., with no gradient) served as a control.  
Surprisingly, nonoxidized control samples (uniform thiol monolayers) 
preadsorbed with 10% human fibrinogen and 10% PFP did see a significant 
increase in adhesion as a function of distance from the flow inlet (n = 20, p < 
0.001) (Figure 2.6 b and d) despite lacking a charge density gradient. Uniform 
thiol monolayers preadsorbed with PFP displayed an adhesion increase in the 0 
mm – 5 mm region, while the same surfaces preadsorbed with fibrinogen 
displayed a significant increase in adhesion over the length of the sample 
(Figures 2.6 b vs. 2.6 d). We infer that the increased downstream adhesion is 
likely due to upstream surface contact activation. Surface fibrinogen-platelet 
interactions convert platelets from a quiescent to a procoagulant state [177]. In 
addition, once platelets adhere to a substrate, they do not always remain there 
and contacts can be transient [173]. Taken together, a downstream increase in 
platelet adhesion may be the result of upstream preactivation.  Control samples 
preadsorbed with 10% human albumin showed a minimal variation of platelet 
adhesion as a function of distance from the flow inlet (Figure 2.6f). Overall, the 
controls with 10 % PFP and 10 % fibrinogen resulted in similar levels of platelet 





Figure 2.6 Effect of negative surface charge density gradients on platelet 
adhesion.  Normalized platelet adhesion on sulfonate-to-thiol gradient samples 
and on non-gradient MTS controls preadsorbed with plasma (panels A,B), 
fibrinogen (panels C,D) and albumin (panels E,F). Adhesion values represent a 
mean ± standard deviation; n = 20. Platelet counts were normalized by dividing 




Sulfonate-to-thiol gradients preadsorbed with 10% human PFP displayed 
a gradient of platelet adhesion compared to the non-gradient control with a 
significant (n = 20, p < 0.001) difference between the negatively charged 
sulfonate region of the gradient and the thiol region of the sample (Figure 2.6a). 
Platelet adhesion increased with respect to the distance from the flow inlet which 
was also inversely related to the surface charge density. These results compare 
well with the previous studies that have shown platelet adhesion to increase with 
increasing hydrophobicity in the presence of plasma proteins [121,125]. The 
chemistry difference between thiol and sulfonate mattered as well: sulfonate 
groups have been incorporated into various biomaterials and shown to improve 
hemocompatibility [178,179]. 
The effect of the surface charge gradient on platelet adhesion and its 
relationship to the nature of the adsorbed protein layer was further investigated 
by preadsorbing a 10% fibrinogen solution prior to platelet perfusion. Interactions 
between fibrinogen and the αIIbβ3 integrin receptors on platelets are central in 
platelet adhesion and aggregation [46,180] thus making it a logical next choice 
for this study. Gradient samples preadsorbed with human fibrinogen displayed an 
adhesion maximum in the center of the gradient region, (Figure 2.6c) an effect 
not observed either on the nonoxidized thiol monolayer control sample (Figure 
2.6d) or gradient preadsorbed with PFP (Figure 2.6 a). This platelet adhesion 
maximum on fibrinogen preadsorbed gradient sample is different than the 
additive effect seen on gradient samples preadsorbed with PFP, thus confirming 
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the importance of not only the surface properties but the nature of the adsorbed 
protein layer as well. 
Gradients preadsorbed with 10% human albumin did not show any 
significant adhesion contrast (Figure 2.6e). Overall platelet adhesion, however, 
on the sulfonate region of the albumin coated gradient sample was somewhat 
higher than on the thiol region for both the uniform thiol control and sulfonate-to-
thiol gradient samples. The lack of an upstream effect on downstream adhesion 
was initially interpreted as being the result of albumin inhibition on platelet 
adhesion [104]. However, contrary to the uniform thiol monolayer data, platelet 
adhesion in the sulfonate region of the gradient samples was somewhat higher 
than in the thiol region of the gradient as well as in thiol controls. In a separate 
study, we found that sulfonate and thiol regions adsorbed similar amounts of 
albumin, implying that the lack of inhibition was not due to the lower amount of 
adsorbed albumin [24].  Significant platelet attachment to albumin coated 
surfaces has been recently reported, presumably due to exposure of a hidden 
binding site for platelets on albumin upon surface adsorption [35]. A conjecture 
can be made that the inhibition of platelet adhesion by adsorbed albumin 
depends more on its conformation than on the variation of adsorbed amount. The 
results here may also indicate that low platelet adhesion to surfaces preadsorbed 
with PFP may not be due to increased albumin adsorption but perhaps to protein 





2.3.4 Effect of Sample Orientation on Platelet Adhesion 
 
To further investigate the effect of upstream conditions on downstream 
platelet adhesion, the orientation of the gradient sample preadsorbed with 10% 
PFP was reversed and compared.  Platelets were perfused over samples with 
the sulfonate region in the upstream position of the flow cell (Figure 2.7a). These 
adhesion patterns were compared with samples with the thiol region in the 
upstream position (Figure 2.7b) before reaching the gradient. Platelet adhesion 
on gradient samples with the upstream sulfonate region displayed similar 
adhesion contrast seen in previous experiments (Figures 2.5a and 2.6a). When 
the orientation of the sample was reversed, adhesion contrast was lost and 
overall adhesion values on the thiol and sulfonate rich regions decreased and 
increased, respectively.  The results support the conclusion that upstream 
platelet-surface interactions could exhibit enhanced downstream adhesion. In the 
surface gradient experiments the relationships between surface composition and 
correlated with the surface properties of that position alone. Thus, it turns out that 
the history of transient surface-platelet interactions must be considered as well. 
Discrepancies between results obtained on gradient vs. control samples were 
also reported by Zelzer et al.  [129]. It is thus crucial we acknowledge these 
inconsistencies when using gradients as a tool to study various biological 
phenomena. 
To reduce the complexity of blood-surface interactions and obtain direct 
insight on the cause-effect relationship between surface chemistry, adsorbed 










Figure 2.7 Effect of sample orientation on platelet adhesion to gradient surfaces. 
Platelet adhesion comparison on sulfonate-to-thiol gradient surfaces with (A) the 
sulfonate region in the upstream position and with (B) the thiol region in the 
upstream position of the flow cell. Samples were preadsorbed with 10% human 












or PRP; however such an approach neglects the effect of red blood cells, which 
have been shown to increase platelet adhesion through a “mixing” effect [181]. 
Although the “mixing effect” could have influenced overall adhesion amounts in 
the experiments described here, it was not expected to significantly affect the 
adhesion contrast seen in these experiments since red blood cells do not actively 
interact with the surface. 
Another concern might be due to the presence of albumin in the platelet 
wash buffer used to prevent premature platelet activation during handling. One 
may question its effect on the nature of the adsorbed protein layer during 
adhesion experiments. The presence of albumin in the wash buffer (3 mg/ml) is 
expected to have little effect on surfaces precoated with albumin since any 
exchange reactions would not change the nature of the protein layer. Surfaces 
preadsorbed with 10% fibrinogen may be affected by the presence of albumin in 
the platelet wash buffer due to the Vroman effect; however this may also be 
unlikely due to the fact that preadsorbed fibrinogen has a higher affinity for 




In this work platelet adhesion on surfaces with varying negative charge 
densities was studied. Platelet adhesion was also related to the nature of the 
adsorbed protein layer (specifically: albumin and fibrinogen). Platelet adhesion 
onto gradients was affected by both the type and concentration of preadsorbed 
protein as well as related to the negative charge density. The high-throughput 




material hemocompatibility in general. However, it is important to consider that 
local surface effect may be affected by the upstream surface-platelet interactions. 
The orientation of gradient samples was shown to affect platelet adhesion 
patterns suggesting that the history of transient surface contacts must be 
considered. 
The ability of platelets to be “preactivated” by the upstream environment 
has many implications for biomaterial hemocompatibility, specifically for of in vitro 
screening studies and in the design of blood-compatible biomaterials.  In the next 
study, an in vitro system was developed to characterize the effect of “priming” 







THE EFFECT OF UPSTREAM PLATELET-FIBRINOGEN  
 







Surface induced platelet adhesion and activation is a dynamic process. 
Platelets attach/detach and roll [43,163,183], before ultimately forming stable 
adhesive interactions. In fact, most platelet-surface contacts are transient [163]. 
Even though transient interactions do not result in local platelet adhesion and 
aggregate formation it is unlikely that they leave the activation state of the 
platelet unaffected. With each surface contact, there is the opportunity to interact 
with plasma protein agonists such as fibrinogen and vWf, both known to activate 
platelets [40,84,184].   
Traditionally, research has worked to establish local cause and effect 
relationships between surface properties and platelet adhesion and activation. 
Quantification of local platelet adhesion [15,106,157,185] and morphological 
changes [186-188] has been widely used to characterize the blood compatibility 
of biomaterials.  In Chapter 2 an increase in platelet adhesion was observed on 
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homogeneous surfaces pre-adsorbed with fibrinogen as a function of distance 
from the flow inlet (2.3.3).  Also, when the orientation of surfaces patterned with 
negative charge density gradients was reversed, adhesion patterns also 
changed.  This led us to hypothesize that upstream-platelet surface interactions 
may affect the downstream platelet response.  Specifically, upstream interactions 
with adsorbed protein agonists may “prime” platelets for downstream adhesion 
and activation. 
In this study, we characterized effect of upstream platelet-fibrinogen 
interactions on downstream adhesion and activation. Micro contact protein 
printing (µCP) was used to covalently immobilize fibrinogen priming regions onto 
reactive substrates.  The downstream platelet response was observed on two 
model surfaces; sulfo-SMCC modified thiol monolayers and commercially 
available Nexterion-H slides.  Downstream adhesion, activation and aggregation 
were significantly higher on Nexterion-H samples containing a fibrinogen priming 
region than control samples.  Also, the increase in downstream adhesion was 
attenuated when the priming region was blocked with a polyclonal antibody for 
fibrinogen suggesting fibrinogen is, in fact, capable of inducing a downstream 
response.  Reactive substrates prepared by sulfo-SMCC modification of thiol 
monolayers [189, 190] did show an increase in adhesion downstream of the 
fibrinogen priming regions however high background platelet adhesion was also 
observed which made the results difficult to elucidate.  The effect of transient 
platelet-surface contacts on bulk platelet activation was also assessed by 
quantifying P-selectin and active αIIbβ3 using flow cytometry.  A slight increase in 
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bulk platelet activation was observed after perfusion over samples prepared with 




3.2.1 Preparation of Reactive Surfaces 
Surfaces capable of protein covalent immobilization were prepared using 
protocols previously established in our lab in which RGD peptides were 
immobilized to thiol monolayers (Appendix A).  Immobilization was achieved 
using a two-step process: preparation of a surface thiol monolayer followed by 
incubation with a heterobifunctional crosslinker, sulfosuccinimidyl-4-(N-
maleimidomethyl)cyclohexane-1-carboxylate (sulfo-SMCC) [189, 190]. The sulfo-
SMCC crosslinker contains an amine reactive N-hydroxysuccinimide (NHS) ester 
and a thiol reactive maleimide group making it an ideal agent for coupling 
proteins to silanized quartz slides. Covalent immobilization was achieved through 
formation of an amide bond between the amine reactive NHS ester group and a 
primary amine on lysine residues in the protein molecule (Figure 3.1). Reactive 
thiol monolayers were prepared following the protocol described in section 2.2.1.  
Silanized FS slides were incubated with sulfo-SMCC (Sigma) in 0.05M PBS (1 
mg/ml, pH 8.5) for 30 minutes.  After the reaction, FS slides were thoroughly 
rinsed in distilled water and dried with N2 gas. All samples were stored under 
vacuum and used for experiments within 1 week. 
A second set of reactive slides (Nexterion-H, Schott) purchased 
commercially were also used for this study.  These slides contain a reactive 
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Figure 3.1 Chemistry of the sulfo-SMCC surface modification process. First, quartz slides are silanized with 3-
mercaptopropyltrimethoxysilane resulting in a monolayer of reactive surface thiol groups. These groups are modified by 
incubation with the heterobifunctional crosslinker sulfo-SMCC. Sulfo-SMCC contains a maleimide on one end which is reactive to 
the thiol monolayer and a reactive NHS ester on the other end which is capable of covalent protein immobilization. 
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with NHS esters providing means for covalent protein immobilization through the 
terminal amine group [191].  These samples provided a comparable protein 
immobilization scheme to sulfo-SMCC modified quartz slides. However, the 
presence of the PEG hydrogel matrix minimized nonspecific protein and platelet 
interactions. 
 
3.2.2 Preparation of Polydimethylsiloxane (PDMS) Stamps for µCP 
 
PDMS stamps were prepared from masks with randomly distributed 
micrometer sized features that were defined to cover 85% of the stamp surface 
area. Mask patterns were developed by generating a 500 x 500 array of 
randomly distributed black and white pixels using Mathematica (Wolfram). 
Patterns were transferred to chromium coated silica wafers using conventional 
photolithography.  First, the pattern was uploaded into a mask making software, 
L-Edit (Tanner), where each pixel was defined to be 25 μm x 25 μm. An 
Electromask MM250 (Interserv Technology) pattern generator was used to 
produce the first mask (Amask = 1.25cm x 1.25cm and Apixel = 25 μm x 25 μm).  
This was followed by two 5x image reductions and one repeat step to produce a 
final mask with a 20 x 20 pattern array of randomly distributed micron sized 
features (Amask = 1cm x 1cm and Apixel = 1 μm x 1 μm). Sylgard 184 silicone 
elastomer (Dow Corning) was mixed with curing agent in a 10:1 ratio and poured 
over the patterned mask.  PDMS was degassed by placing the samples under 
vacuum for 30 minutes.  The samples were cured for 30 minutes at 100°C and 
carefully peeled away from the mask to remove the patterned stamps.  This was 
followed by an additional 60 minutes of curing at 60°C.  After curing the stamps 
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were incubated overnight in hexane to remove any polymer that did not crosslink.  
To eliminate swelling that occurred after hexane incubation, stamps were rinsed 
for 30 minutes in a 95% ethanol solution, 30 minutes in Milli Q water, and dried 
for 30 minutes at 60°C.  
 
3.2.3 Sample Preparation Using µCP 
 
Printing on sulfo-SMCC Samples: PDMS stamps were “inked” with either 
fibrinogen or albumin in PBS (c = 1 mg/ml, pH 8.5) for 15 minutes, rinsed in Milli-
Q water and dried with N2 gas.  The fibrinogen covered stamps were placed in 
contact with 490 Pa of pressure applied evenly using a 5g weight.  PDMS stamps 
were positioned in the center of sulfo-SMCC reactive slides for 45 minutes 
allowing for protein covalent immobilization (Figure 3.2a). Following protein 
immobilization, samples were vigorously rinsed in a 1% Tween solution to 
remove any protein not covalently immobilized on the surface. Samples were 
then rinsed thoroughly with Milli-Q water, dried with N2 gas and stored under 
vacuum until use. 
Preparation of Nexterion H Samples: PDMS Stamps were “inked” with 
human fibrinogen in PBS (c = 1 mg/ml, pH 8.5) for 15 minutes, rinsed in Milli-Q 
water and dried with N2 gas.  The fibrinogen coated stamps were placed in 
contact with Nexterion-H (Schott) reactive slides under the same conditions as 
described for sulfo-SMCC reactive samples above. A fibrinogen “priming” region 
was printed in the upstream region on test samples and a platelet capture region 




Figure 3.2 Sample preparation using µCP:  (A) sulfo-SMCC and Nexterion-H test 
samples were prepared with covalently immobilized protein patterns using µCP. 
(B) A schematic representation of the µCP process.  First PDMS stamps are cast 
and cured in patterned masks.  The stamps are transferred to a protein solution 
where they are “inked” by allowing the protein to adsorb to the surface.  The 
protein coated stamp is placed in contact with the reactive surface allowing the 
protein transfer to occur. On Nexterion-H substrates, the printed surface was 






fibrinogen was printed, the nonreacted regions were passivated by incubating the 
samples in an albumin solution in PBS(c = 1 mg/ml, pH 8.5) for 30 minutes 
(Figure 3.2b).  Albumin was chosen over small molecules such as ethanolamine 
for background passivation because it demonstrated an improved ability to 
eliminate platelet adhesion (data not shown).  Following protein immobilization, 
samples were vigorously rinsed in a 1% Tween solution to remove any protein 
not covalently immobilized on the surface. Samples were then rinsed thoroughly 
with Milli-Q water, dried with N2 gas and stored under vacuum until use. A 
schematic of the µCP procedure is shown in Figure 3.2b. 
 
3.2.4 Surface Characterization 
 
Thiol monolayers were prepared and characterized as described in 
sections 2.2.1 and 2.3.1.  The conjugation of sulfo-SMCC to surface thiols was 
confirmed water contact angle.  Briefly, receding water contact angles were 
measured along the length of the sample using a contact angle instrument (CAM 
100, KSV Instruments).  The average contact angle for the surface was 
calculated before and after sulfo-SMCC incubation of the thiol monolayers.   The 
conjugation protocol of sulfo-SMCC to an MTS thiol monolayer for RGD peptide 
immobilization has been characterized with ESCA and ToF SIMS analysis in our 
lab previously (Appendix A).  
The integrity of the protein patterns and the protein transfer efficiency was 
characterized visually using fluorescence microscopy and by lateral force 
microscopy.  LFM measurements were obtained in air on an Explorer AFM 
(TopoMetrix) with silicon cantilevers (Mikromasch) having a force constant of 
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0.03 N/m and a radius of curvature < 10nm.  These measurements (n = 10) were 
used to compare the actual printed protein area with target values. 
 
3.2.5 Fibrinogen Labeling 
  
In order to visualize immobilized protein patterns, fibrinogen was labeled 
with Alexa Fluor 488 succinimidyl ester (Invitrogen).  Human fibrinogen (c = 10 
mg/ml, Calbiochem) in 0.1M sodium bicarbonate buffer (pH 8.5) was incubated 
for 2 hours with Alexa Fluor 488 (c = 0.25 mg/ml).  After incubation, the protein 
solution was loaded into a PD-10 desalting column (GE Healthcare) which 
excludes molecules according to size and was used separate labeled fibrinogen 
from unlabeled fluorophores.  Labeled protein was eluted with a protein printing 
buffer (Schott, pH 8.5). Protein aggregates were filtered out using 0.22 µm low 
protein binding PES syringe filters (Millipore) and the labeled protein was 
immediately frozen at -20 °C until use. 
 
3.2.5 Blocking Immobilized Fibrinogen Priming Regions 
 
Control samples were prepared by blocking the upstream fibrinogen 
region with a rabbit α-polyclonal antibody raised against human fibrinogen, 
(Calbiochem).  Blocking was achieved by selectively incubating the priming 
region with 1:100 dilution of anti-fibrinogen in 0.1M PBS (ph 7.4) for 30 minutes.  
The samples were rinsed three times in Milli-Q water following blocking, and 





3.2.6 Platelet Adhesion Studies  
Fresh whole blood was collected from healthy human donors in a 1:7 ACD 
solution.  Washed platelets were prepared as described in section 2.24. Briefly, 
whole blood was centrifuged for 15 minutes at 1500 rpm to separate platelet rich 
plasma (PRP).  The PRP supernatant was aspirated off using a transfer pipette. 
Prostaglandin E1 (PGE1, 300 nM) was added to the PRP to inhibit aggregation 
during preparation [173].  PRP was then centrifuged for another 15 minutes at 
2100 rpm to isolate the platelet pellet.  The platelet poor plasma (PPP) 
supernatant was carefully discarded and the platelet pellet was gently re-
suspended in prewarmed Tyrodes-HEPES buffer (37 ⁰C, pH 7.4) [174]. Platelets 
were counted using a hemocytometer and the concentration was adjusted to 2.5 
•107 platelets/ml. 
Platelet perfusion studies were conducted in a parallel plate flow cell as 
described in section 2.2.5.  Adhesion was quantified by averaging samples 
(n=30) downstream of the priming region.  In studies where Nexterion-H reactive 
substrates were used, average platelet spreading area and the number of 
aggregates per sample was also calculated.  Area values were obtained by 
taking the average area of 100 spreading platelets in the downstream region.  
Platelet aggregates were defined as a cluster of 3 or more platelets and the 
average number per sample was quantified (n = 30).  Significance between data 





3.2.7 Flow Cytometry  
Flow cytometry was used to measure levels of expressed P-selectin and 
the active conformation of integrin αIIbβ3 on the membranes of platelets.  
Following platelet perfusion over samples printed with both albumin and 
fibrinogen, a 100 µl aliquot of the platelet supernatant was collected and 
incubated for 30 minutes with either anti-CD62P (BD Biosciences) or PAC-1 (BD 
Biosciences) to label P-selectin and active αIIbβ3,  respectively (c = 1 µg/ml, BD 
Biosciences).  Also, two 100 µl aliquots were obtained and labeled prior to 
perfusion.  One sample was stimulated by addition of thrombin immediately prior 
to labeling (c = 0.1 units/ml) and the other was left un-stimulated to serve as 
positive and negative controls, respectively.  In order to ensure platelets are 
properly identified, they were also labeled with CD41b (BD Biosciences) which 
binds to the αIIb subunit of integrin αIIbβ3 regardless of the activation state of the 
receptor.  Rat monoclonal anti-mouse IgG and IgM served as a negative control 
for P-selectin and PAC-1 test samples, respectively.  Following labeling, platelets 
were fixed in 1% paraformaldehyde and stored at 4°C.  Analysis of 10,000 events 
was conducted on a FACScan (BD Biosciences) analyzer. 
 
 3.3 Results and Discussion 
 
3.3.1 Surface Characterization 
The preparation of thiol monolayers was characterized previously (Section 
2.3.1).  The functionalization of surface thiol groups with reactive NHS ester 






Figure 3.3 Characterization of sulfo-SMCC surface modification and printing 
protein micropatterns: (A) Receding water contact angles were measured to 
confirm the modification of the thiol monolayer contain a reactive NHS ester 
surface chemistry.  Prior to sulfo-SMCC incubation the average contact angle 
was measured to be 50° +/- 1.7°.  (B) After incubation the average contact angle 
reduced to 37° +/- 3° suggesting the surface was in fact modified.  PDMS stamps 
for printing were prepared with a mask defined with an 85% feature coverage 
area (C). The integrity of the printed protein patterns after surfactant rinsing was 
confirmed by (D) fluorescence microscopy.  LFM microscopy (E) was used to 






length of the sample (Figures 3.3a and 3.3b) before and after sulfo-SMCC 
incubation.  Thiol modified samples had an average receding water contact angle 
of 50° +/- 1.7°, an expected value for this surface modification scheme [192]. 
After sulfo-SMCC incubation, a reduction in the average receding water contact 
angle was observed to 37° +/- 3°, suggesting the surface was in fact modified. 
Furthermore, previous studies in our lab have shown an increase in the atomic 
percentage of elemental nitrogen and carbon following sulfo-SMCC incubation of 
a thiol monolayer (Appendix A). 
Fluorescence images of 85% printed protein micropatterns (Figure 3.3c) 
were acquired to qualitatively assess the integrity of printed fibrinogen patterns 
and ensure no major defects were present. Figure 3.3d provides a representative 
image for fibrinogen printed surfaces.  The same technique was also used for 
albumin printed surfaces (data not shown). These images were also acquired 
after samples were vigorously rinsed in a 1% Tween solution suggesting the 
protein present on the surface was, in fact, covalently immobilized. 
In order to determine the efficiency of protein transfer, samples were 
scanned with LFM. This technique measures deflections of a cantilever tip that 
arise from variations in friction over heterogeneous surfaces providing contrast 
between the printed and nonprinted regions.  LFM images showed good contrast 
between the printed (dark grey) and non printed (light grey) (Figure 3.3e) regions.  
For these studies, PDMS stamps with a target protein coverage area of 85% 
were used for printing.  The actual printed coverage area was quantified for each 
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LFM sample (n=10) and found to be 85.5% +/- 0.9%, suggesting an accurate 
protein transfer efficiency. 
 
3.3.2 Effect of Priming Platelets with Fibrinogen Immobilized 
to SMCC Modified Surfaces on Downstream 
Adhesion, Activation, and Aggregation 
 
Surface adsorbed proteins, such as fibrinogen, are capable of activating 
quiescent circulating platelets independent of other activation agonists [193]. 
Here, a fibrinogen priming region was covalently immobilized to SMCC reactive 
substrates using µCP and the effect on downstream adhesion was quantified.  
Average adhesion was calculated in a 25 mm2 area at a distance of 5mm-9mm 
downstream from the priming region (Figure 3.4).  These adhesion values were 
compared with samples that contained covalently immobilized albumin and no 
priming regions.   All values were normalized against background adhesion that 
occurred on bare sulfo-SMCC modified surfaces upstream of the priming region.  
Error bars represent the standard error of the mean with a confidence interval of 
95% (n = 30).  A significant increase (p < 0.001) in downstream adhesion on 
fibrinogen samples was observed suggesting that immobilized fibrinogen is 
capable of transiently interacting with platelets, promoting downstream adhesion.  
No significant increase in downstream adhesion occurred on samples without a 
printed priming region.  Interestingly, a significant increase in downstream 
adhesion was also observed on albumin samples although this increase was not 
as substantial as the increase on fibrinogen printed samples.   This was 
surprising since albumin is believed to be relatively inert to platelet adhesion and 








Figure 3.4 The effect of “priming” platelets with immobilized fibrinogen on sulfo-
SMCC substrates.  Downstream adhesion was quantified by covalently 
immobilizing fibrinogen and albumin to the reactive samples using µCP. These 
values were compared with samples that did not contain a priming region (n = 










is that adhesion in the stamped region was highest on albumin printed samples 
which again is counterintuitive since fibrinogen is a known platelet adhesive 
ligand and albumin is not.   
Recently Sivaraman et al. discovered that immobilized albumin is capable 
of supporting platelet adhesion and that this is dependent on the exposure of a 
binding epitope upon surface-induced unfolding. [35]. Therefore it is possible that  
platelet interactions with albumin may induce some amount of surface activation.  
However, it is still unlikely that adhesion would be drastically larger on albumin 
vs. fibrinogen stamped regions. 
A substantial amount of platelet adhesion was observed on bare sulfo-
SMCC surfaces with no immobilized protein ligands present (data not shown).  
Priming regions were printed with 85% relative coverage areas leaving 15% of 
the area of the background sulfo-SMCC surface exposed.   It is therefore more 
likely that results are representative of platelet interactions with the background 
substrate.  It was concluded that experiments should be redesigned with a 
substrate background that could be passivated, providing a more accurate 
representation of the downstream adhesion effect of immobilized upstream 
fibrinogen. 
 
3.3.3 Effect of Priming Platelets with Fibrinogen Immobilized 
to PEG Hydrogel Substrate  on Downstream  
Adhesion, Activation, and Aggregation 
 
In order to reduce the background effect described in 3.3.2, experiments 
were redesigned with commercially purchased Nexterion-H glass slides.  These 
substrates are coated with a PEG based hydrogel matrix functionalized with 
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reactive NHS ester groups providing a mechanism for protein covalent 
immobilization [194].   PEG based surface coatings have been shown to 
drastically reduce nonspecific protein adsorption and cell adhesion 
[18,100,106,191,194] making Nexterion-H slides better model substrates for the 
subsequent experiments.    
Here, samples were prepared with a covalently immobilized fibrinogen 
priming and capture region as described above (3.2.3) with 85% coverage area 
stamps.  The background was passivated with covalently immobilized albumin.  
The effect of fibrinogen priming on the downstream platelet response was 
quantified by comparing overall average adhesion, spreading area, and 
aggregate formation in the downstream capture region with controls that did not 
contain a priming region (Figure 3.5).  Aggregates were defined as 3 or more 
platelets in a single cluster.  In all three cases, adhesion, spreading area, and 
aggregation were significantly higher on samples with the fibrinogen priming 
region (p < 0.001), suggesting that upstream platelet-protein interactions are 
capable of eliciting a downstream response. 
 To explicitly confirm that the presence of the upstream immobilized 
priming region is amplifying the downstream platelet response, a test sample was 
prepared with the upstream priming region blocked by a polyclonal antibody for 
fibrinogen.  Average adhesion in the downstream capture region was compared 
with adhesion values on samples with and without an upstream fibrinogen 
priming region (Figure 3.6).  Platelet adhesion on samples primed with upstream 




Figure 3.5 Effect of an upstream immobilized fibrinogen priming region on 
downstream (A) adhesion, (B) aggregation, and (C) spreading area on Nexterion-
H substrates.   Samples (n = 30) were acquired 10-15mm downstream of the 
priming region. The error bars represent the standard error of the mean with a 








Figure 3.6 Blocking fibrinogen priming region with an anti-fibrinogen polyclonal 
antibody attenuates the downstream adhesion response.  The effect of priming 
platelets with immobilized upstream fibrinogen on downstream adhesion was 
compared with samples containing no priming region and a priming region 
blocked with an anti-fibrinogen polyclonal antibody.  Samples (n = 30) in the 
downstream capture region were averaged and error bars represent the standard 











upstream priming region.  Also, when the upstream priming region was blocked 
with an antihuman fibrinogen polyclonal antibody the downstream platelet 
adhesive response was attenuated and there was no significant difference with 
unprimed samples (p < 0.001).  These results further confirm that the presence of 
upstream immobilized protein agonists can in fact prime platelets for downstream 
adhesion. Traditionally, blood compatibility studies focus on establishing the local 
platelet response to the biomaterial.  However, since platelet surface interactions 
are often transient [163], these studies may not be sufficient to understand the 
whole picture. Platelet membrane receptor interactions with surface immobilized 
proteins, such as vWf-GPIb-IX-V and fibrinogen-αIIbβ3, are capable of activating 
platelets [40,42,81,84,184].  It is unlikely that these transient contacts leave the 
phenotype unchanged. For example, upstream platelet activation on devices 
such as prosthetic heart valves and stents has been shown to cause downstream 
thromboembolic complications [5,195]. Also, it has been hypothesized that 
transient platelet-surface interactions trigger platelet microparticle formation at 
the site of contact [187]. Platelet microparticles have procoagulant surface 
properties and may have serious blood compatibility implications in the absence 
of stable platelet adhesion [196,197].  It is evident that the “history” of transient 
platelet-substrate contacts is an important consideration in the design of in vitro 
blood compatibility studies. 
Characterizing the effect of transient interactions on the downstream 
platelet response is also an important aspect in the development of 
cardiovascular devices.  When a device such as a vascular graft or heart valve is 
89 
 
implanted there exists a region in which the native vessel is joined with the 
synthetic material.  This region, also known as the anastomotic region, is 
characterized by high rates of stenosis (narrowing) and subsequently, higher fluid 
shear rates [100].  The anastomosis is also characterized by adsorption of pro-
coagulant proteins such as fibrinogen due to damage of the vessel endothelium 
at this location [198].  This presents an ideal environment for platelet activation to 
occur and may have serious consequences for the blood compatibility of the 
downstream biomaterial.  Another implication is in the use of grafts or shunts in 
hemodialysis patients. Traditionally, the most common cause of arteriovenous 
graft failure is neointimal hyperplasia at the graft-venous anastomoses [164,165].  
The exact mechanism is not yet understood.  However, it has been suggested 
that the physiology of the venous endothelial layer may play a role [165]. It is 
possible however, that the upstream artery-graft anastomoses may be 
preactivating platelets for downstream adhesion since this region is characterized 
by both high shear forces as well as a damaged endothelial layer.  In order to 
better understand the role of platelet activation in device failure we must take into 
account the transient nature of adhesion and activation.  This will, in turn, help us 
develop more hemocompatible biomaterials.   
Here, we established that immobilized fibrinogen is capable of priming 
platelets for downstream adhesion, activation and aggregation which has 
implications for both the design of in vitro blood compatibility studies as well as 
the development of blood compatible medical devices.  However, as discussed 
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above, platelet contacts are mostly transient therefore it is also important to 
characterize the effect of fibrinogen priming on the bulk platelet response. 
 
3.3.5 Evaluation of PAC-1 and P-Selectin Expression on  
Platelets Primed by Upstream Protein Agonists 
 
Platelet interactions with immobilized protein agonists may be transient 
[163].  However, even in the absence of an adhesion event these transient 
interactions may be capable of activating platelets.  In section 3.3.4 we found that 
upstream immobilized fibrinogen was capable of increasing the platelet response 
downstream.  To further investigate this phenomenon our goal was to 
characterize the bulk platelet response to surface immobilized fibrinogen.   
PAC-1 recognizes an epitope on the integrin αIIbβ3 complex of activated 
platelets near the fibrinogen receptor. Platelet activation induces a calcium-
dependent conformational change in integrin αIIbβ3 that exposes a ligand binding 
site thus PAC-1 binds only to activated platelets [52].  P-Selectin is stored in the 
α-granules of platelets and is rapidly transported to the platelet membrane upon 
activation [199].   Here, platelets were fluorescently labeled for PAC-1 and P-
selectin following perfusion over samples containing immobilized fibrinogen and 
albumin. Unstimulated platelets and thrombin activated platelets were collected 
prior to perfusion and served as negative and positive controls, respectively.  
Expression of each receptor was quantified by detecting 10,000 events using 
flow cytometry. 
 Slight increases in P-selectin and PAC-1 were observed on samples 
perfused over fibrinogen coated versus albumin coated substrates and negative
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controls (Figure 3.7).  It should be noted that the negative control had a relatively 
high level of PAC-1 expression at 62.52%, which suggests that some amount of 
platelet activation occurred prior to this study. To confirm that this observation is 
conserved, the study could be expanded to test platelets from more than one 
donor.  Furthermore, the increase in expression for both markers was 
appreciably low when compared to thrombin activated positive controls, making 
the observed results less convincing.  However, if one considers the number of 
platelets capable of interacting with the surface compared to the total bulk 
platelet concentration, the slight differences can be explained.   
According to the Von Smoluchowski-Levich approximation, the platelet 
flux to the surface in a parallel plate flow cell can be modeled by the following 
equation [200-202]: 
 
   
     
    
 
   
     
 




where j* = the instantaneous platelet flux [platelets/cm2-sec] to the interface, Dplt = 
diffusion coefficient, c = bulk platelet concentration (~2.5∙107 platelets/ml), a = 
platelet radius (~ 1 μm), b = ½ the height of the flow cell, Pe = Peclet number 
(ratio of convective to diffusive transport, see Appendix B) and x = position in the 
flow cell. This assumes the flow is laminar and fully developed (for full derivation 
see Appendix B). According to this model, the deposition rate changes with the 
position x (distance from the flow inlet) due to the presence of a hydrodynamic 
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Figure 3.7 Flow cytometry analysis of bulk platelet activation for one human donor. Pac-1 and P-selectin expression on 
platelets were quantified after perfusion over albumin and fibrinogen substrates. These samples were also compared with 
an unstimulated and thrombin activated sample collected prior to perfusion. Values are recorded as a percent of positive 
events that occurred out of 10,000 events recorded. 
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for the sample volume of platelets to travel through the flow cell you obtain the 
overall deposition rate as a function of distance from the flow inlet per area 
(Figure 3.8).  If platelets are assumed to be spheres, Dplt can be estimated using 
the Stokes-Einstein relationship:  
 
 
      
   
    
 
where kb = the Boltzman constant (1.3806503 × 10
-23 m2 kg s-2 K-1), T = absolute 
temperature (310.15K = 37° C) and μ = absolute viscosity, making Dplt ≈ 10
-13 
m2/sec (For complete set of calculations see Appendix B). 
The average platelet deposition rate in the center of the substrate 
(between 2cm ≤ x ≤ 5cm) where fibrinogen was immobilized was calculated to be 
~36 platelets/cm2-sec.  If you multiply this by the time it takes for one sample 
volume (0.1 ml) to travel over the area of printed fibrinogen (t = 18 sec, A = 1.5 
cm2) the total number of platelet contacts per sample is ~964 platelets. This only 
represents approximately 0.04% of the total platelets present in the bulk solution 
(~2,500,000).  Consequently, it is not surprising that increases in activation due 
to platelet surface-interactions are small when compared to the total number of 
platelets in the bulk sample.  It is also important to note that platelet and 
coagulation mechanisms are inherently designed to be amplified in the 
physiological environment so even a small amount of activation can be 
significant.  It should be noted that this approximation does not take into account 







Figure 3.8 Platelet deposition rate in a parallel plate flow cell as predicted by the 
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electrostatic interactions.  It is impossible to obtain analytical solutions including 
these variables although some numerical solutions do exist [200, 203]. One way 
to further confirm that the slight increases in bulk platelet activation are in fact 
due to platelet interactions with fibrinogen at the surface is to try and amplify the 
response.  This can be done by changing parameters such as the surface area of 
immobilized fibrinogen available to platelets and the flow rate of the washed 
platelet suspension , both resulting in an increase in the potential platelet 




In this study, the effect of priming platelets with covalently immobilized 
fibrinogen on the downstream platelet response was investigated. Priming 
regions were prepared using µCP on surfaces capable of protein covalent 
immobilization. Initially, test samples were prepared by modifying silanized quartz 
slides with the heterobifunctional crosslinker, sulfo-SMCC.  Unfortunately, these 
samples also resulted in high background platelet adhesion which made the 
results difficult to decipher.  The use of commercially available Nexterion-H slides 
with a PEG based surface chemistry eliminated this background response and 
therefore was used as the model substrate.  The difference in the platelet 
response to these two substrates was believed to be primarily due to the 
presence of the PEG hydrogel on the surface. However, it is also possible the 
protein immobilization scheme may affect the conformation of fibrinogen (See 




The downstream platelet response on PEG based model substrates was 
quantified by comparing adhesion, spreading area, and aggregation values with 
control samples that did not contain an upstream priming region.  The results 
presented suggest that immobilized fibrinogen is capable of priming platelets and 
their response may be transient.  The effect on immobilized fibrinogen on the 
bulk platelet activation was also quantified by measuring expression levels of P-
selectin and PAC-1 expression. Although slight, there was an increase in 
expression after perfusion over fibrinogen substrates. This has both clinical 
significance and will be an important consideration in the design of future in vitro 
studies. 
 The work described in this chapter used µCP to prepare surface 
immobilized fibrinogen regions in well defined positions on the sample.  The use 
of µCP to design well-defined protein patterns has many other potential 
applications for in vitro platelet studies.  In the next chapter, we developed 
random fibrinogen micropatterns with three different relative coverage areas 
(20%, 50%, and 85%).  The ability of these patterns to control platelet adhesion 
and spreading morphologies was explored.  If good morphological control could 
be achieved, these well-defined patterns could be applied to study fundamental 
platelet adhesion and activation using similar methods that have been applied to 
other cells on µCP substrates [120, 134-136, 145]. 
CHAPTER 4 
 
WELL DEFINED FIBRINOGEN MICROPATTERNS FOR  
ADHESION AND ACTIVATION STUDIES PREPARED  




As discussed in section 1.2.2, platelet adhesion is supported by 
interactions between GPIb-V-IX and integrin αIIbβ3 with vWf and fibrinogen 
respectively [53,61,66,181].  Specifically, GPIb-V-IX binds to surface immobilized 
vWf to arrest platelets in flowing conditions.  Although this interaction is weak and 
reversible, it is crucial in facilitating stable integrin αIIbβ3 fibrinogen binding, thus 
both proteins work synergistically to promote stable platelet adhesion 
[45,212,213]. 
Following adhesion, platelet activation is characterized by morphological 
changes including the extension of filopods, lamelipod formation, and spreading 
as more specific adhesive contacts with adsorbed protein ligands are 
established.  Activation also leads to the up-regulation of high affinity binding 
sites for adhesion proteins involved in further platelet adhesion, activation and 
aggregation [166,214,215]. Platelet spreading also facilitates the centralization of
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granules that secrete procoagulant factors involved in further platelet recruitment 
and activation [166].  An extensive amount of effort has been devoted to 
understanding both adhesion and activation; however, many of the mechanisms 
are still not well understood.  Although in vivo models provide the most accurate 
conditions to study these mechanisms, it is often difficult elucidate cause and 
effect relationships because the biochemical events are complex and highly 
interdependent.  The ability to develop well controlled studies in vitro, where 
specific platelet interactions with the surface are promoted or inhibited, is crucial 
in developing an improved understanding of basic activation mechanisms.   
Microcontact printing (µCP) has demonstrated to be a powerful technique 
in many fundamental cell biology studies [135].  This tool is capable of generating 
well-defined patterns of immobilized protein ligands in which the type, size, 
shape and spacing are precisely controlled [145].  As discussed in section 1.3, 
µCP of proteins has been used to study many different cell phenomena including 
adhesion, migration, apoptosis and proliferation [118,120,135,136]. This 
technique has also been used to pattern 2-D protein arrays for high-throughput 
drug screening and disease diagnosis [216]. 
Microcontact printing has shown potential value in many platelet adhesion 
and activation studies. As discussed in section 1.3.3, Basabe-Desmonts et al. 
demonstrated platelets could be isolated from whole blood using micro contact 
printed dots of platelet specific protein ligands demonstrating a potential 
application of µCP in the development of platelet functionality assays and 
fundamental adhesion and activation studies [152]. Kastrup et al. used protein 
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patterning to control a coagulation stimuli patch size discovered that there exists 
a threshold initiation response [217].  However, despite these efforts, the 
application of µCP to fundamental platelet adhesion studies is still relatively new.   
In this work, well-defined fibrinogen patterns were covalently immobilized 
to reactive substrates using µCP.  Stamps with three randomly patterned 
coverage areas (20%, 50%, and 85%) were generated and used for printing.  
Increasing the surface coverage area also increased the size of the fibrinogen 
features due to the merging of randomly placed islands. Nonprinted regions of 
the substrate were passivated with covalently immobilized albumin.   The effect 
of varying the average fibrinogen feature size on platelet adhesion activation was 
observed and quantified using combined differential interference contrast (DIC), 
fluorescence, and scanning electron microscopy (SEM). Our aim was to 
investigate the extent in which the underlying fibrinogen pattern was able to 
control platelet spreading morphology.  We found that both overall adhesion and 
activation could be controlled by varying the immobilized fibrinogen island size.  
Platelet morphology was also observed to be controlled by the underlying 
fibrinogen pattern.  These studies have the potential to serve as a basis for future 
work in which the adhesion response morphological parameters can be 













4.2.1 Preparation of PDMS Stamps and Printing  
Immobilized Fibrinogen Patterns 
 
The protocol described in 3.2.1 was used to produce PDMS stamps with 
85%, 50%, and 20% relative surface coverage areas.  Stamps were “inked” with 
fibrinogen in PBS (c = 1 mg/ml, pH 8.5) for 15 minutes, rinsed in Milli-Q water 
and dried with N2 gas.  The fibrinogen covered stamps were placed in contact 
with Nexterion-H (Schott) reactive slides for 45 minutes with 490 Pa of pressure 
applied evenly using 5g of weight (See Figure 3.3). These slides are coated PEG 
hydrogels functionalized with terminal reactive NHS groups and are capable of 
protein covalent immobilization [187].    After fibrinogen was printed, the non-
reacted regions were passivated by incubating the samples in an albumin 
solution in PBS (c = 1 mg/ml, pH 8.5) for 30 minutes.  Following protein 
immobilization, samples were vigorously rinsed in a 1% Tween solution to 
remove any protein not covalently immobilized on the surface. Samples were 
then rinsed thoroughly with Milli-Q water, dried with N2 gas and stored under 
vacuum until use. 
 
4.2.2 Surface Characterization 
 
Lateral force microscopy (LFM) was used to characterize the printed 
fibrinogen samples for each relative surface coverage area (20%, 50%, and 
85%).  Measurements were obtained in air on an Explorer AFM (TopoMetrix, 
Santa Clara, CA) with silicon cantilevers (Mikromasch, San Jose CA) having a 
force constant of 0.03 N/m and a radius of curvature < 10nm.  Lateral force on 
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the cantilever tip was recorded (A = 50 µm x 50 µm) for each fibrinogen pattern 
(n=10) and ImageJ (Rasband, NH) was used to quantify the area of the 
fibrinogen features. The integrity of the fibrinogen patterns was also confirmed 
using fluorescence microscopy.  First, fibrinogen was labeled with Alexa Fluor-
488 ® (Invitrogen) following the protocol described in section 3.2.5 and then 
printed onto Nexterion reactive slides following the stamping protocol described 
in section 3.2.3. 
 
4.2.3 Platelet Adhesion Studies 
 
Fresh whole blood was collected from healthy human donors in a 1:7 ACD 
solution and washed platelets were prepared as described in section 2.24. 
Briefly, the blood was centrifuged for 15 minutes at 1500 rpm to separate platelet 
rich plasma (PRP).  The PRP supernatant was transferred to a clean 
polypropylene test tube using a transfer pipette. Prostaglandin E1 (PGE1, 300 
nM) was added to the PRP to inhibit aggregation during preparation [174].  PRP 
was centrifuged for another 15 minutes at 2800 rpm to isolate the platelet pellet.  
The platelet poor plasma (PPP) supernatant was carefully discarded and the 
platelet pellet was gently resuspended in prewarmed Tyrodes-HEPES buffer (37 
⁰C, pH 7.4) [175]. Platelets were counted using a hemocytometer and the 
concentration was adjusted to 1•107 platelets/ml (~10% of physiological 
concentration). The washed platelet suspension was maintained at 37⁰C prior to 
each experiment. Patterned samples were incubated in the washed platelet 
suspension for 5 minutes and rinsed twice with PBS to remove unbound 
platelets.  Samples were fixed with 3.2 % glutaraldehyde (t = 30 min) and rinsed 
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a final 3 times with PBS.  In order to characterize the platelet response to each 
fibrinogen coverage area, adhesion, spreading area, and circularity were 
calculated.  First platelets were visualized using a DIC microscope.  Overall 
adhesion was quantified by calculating the average adhesion (n = 30) for each 
surface coverage.  Spreading area and circularity were calculated by measuring 
the average area and perimeter for platelets (n = 100) on 5 different samples for 
each relative fibrinogen coverage.  Circularity (C) is a ratio between the area, A, 
and the perimeter, P, that can be used to describe cell morphology (C = 4πA/P2). 
When C = 1 the shape is a perfect circle corresponding to a fully spread platelet.  
For each data set, standard error of the mean was calculated using a 95% 
confidence interval and statistical significance was calculated using an unpaired 
t-test. 
 
4.2.4 SEM Morphological Analysis 
 
Fixed platelet samples were first dehydrated by incubating in ascending 
ethanol (50%, 75%, 100%) solutions for 15 minutes each.  Samples were then 
dried and sputter coated with a 10 nm layer of gold with a Cressington 108 Auto 
sputter coater.  SEM images were obtained using a Hitachi S-3000N SEM at 20 
kV. 
 
4.3 Results and Discussion 
 
4.3.1 Immobilized Fibrinogen Pattern Characterization 
Microcontact protein printing was used to covalently immobilize µm-sized 
human fibrinogen islands to Nexterion-H slides at a relative surface coverage of 
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20%, 50%, or 85%.  Printing protein ligands was chosen due to its ability to 
reproducibly generate well-defined patterns [218]. Covalent immobilization on 
reactive substrates maintained the integrity and stability of the patterns, ensuring 
no desorption or leaching of immobilized protein over time. Furthermore, 
Nexterion-H slides are coated with a thin PEG-based hydrogel modified with 
terminal NHS ester groups and show minimal tendency for nonspecific protein 
adsorption and low platelet adhesion [194]. In addition, after fibrinogen 
immobilization, samples were backfilled by covalently immobilized albumin to 
further passivate the nonprinted regions since albumin is known as being inert to 
platelets [158].  The integrity of the surface, the size of the fibrinogen islands and 
the printing efficiency were characterized using both fluorescence and LFM.  
Samples were vigorously rinsed in a 1% Tween surfactant solution to remove 
nonspecifically immobilized protein. Alexa Fluor-488 labeled fibrinogen surface 
patterns were visualized after surfactant treatment suggesting the protein was 
covalently immobilized (Figure 4.1b).   Examining fibrinogen surface patterns by 
fluorescence microscopy was used to assess the integrity of the fibrinogen 
patterns and ensure no defects were present prior to conducting experiments.   
LFM was used to characterize the average protein feature size and the 
printing efficiency of the PDMS stamps at each fibrinogen coverage area (Figure 
4.1c).  LFM images showed good contrast between the printed fibrinogen and 
nonprinted albumin regions. The actual coverage of printed fibrinogen was 
quantified for each sample (n=10) and compared with target values (Table 4.1).  





Figure 4.1 Fluorescence and LFM surface characterization of protein 
micropatterns: (A) Patterns used to generate photomasks, (B) Representative 
fluorescence (green = Alexa Fluor 488 labeled fibrinogen) and (C) lateral force 
AFM images (orange = fibrinogen islands) of 20%, 50% and 85% relative surface 

























the fidelity of protein transfer.  The mean fibrinogen island size on 20% coverage 
samples was 5.3 +/- 0.4 µm2.  The background albumin pattern was completely 
interconnected thus calculating an average size was not possible.  At 50%, the 
average fibrinogen and albumin feature sizes were 84.1 +/- 31.4 µm2 and 68.2 
+/- 34.0 µm2, respectively.  Large standard deviation was observed suggesting 
heterogeneous distribution of island sizes on these samples. At 85% the printed 
fibrinogen features were completely interconnected.  The mean albumin island 
size was 4.8 +/- 0.6 µm2. 
 
4.3.2 Adhesion and Spreading on Surfaces  
with Varied Fibrinogen Coverage 
 
The effect of the underlying fibrinogen pattern on platelet adhesion and 
spreading was studied by printing randomly placed µm-sized fibrinogen islands at 
different relative surface coverage areas (20%, 50%, or 85%). Due to the random 
nature of island placement, each coverage area corresponded to a different 
population of printed islands thus correlations could be made based on the size 
and shape of the stimuli presented to platelets.  Fibrinogen was selected due to 
its multiple roles in platelet adhesion, activation and aggregation [72,40].  
Covalent protein immobilization and the use of diluted washed platelet 
suspensions were chosen to control the surface protein content and ensured the 
phenomena observed was solely due to platelet-fibrinogen interactions.  The 
washed platelet concentration was optimized at 107 platelets/ml to minimize 
platelet-platelet recruitment and aggregation. On each substrate AlexaFluor-488 




Figure 4.2 Platelet adhesion to covalently immobilized fibrinogen micropatterns at 
coverage areas of 20%, 50% and 85%.  Nonprinted regions were blocked with 
covalently immobilized albumin.  The top and middle rows contain fluorescence 
images of fibrinogen patterns and DIC images of platelet adhesion and spreading 
respectively. The bottom row includes superimposed images where at 20% (A) 
platelets rarely spread and when they do their size was strictly limited by the size 
of the underlying fibrinogen pattern. At 50% (B) platelets are able to spread but 
their morphology almost strictly depends on the shape of the underlying 
fibrinogen pattern. At 85% (C) platelets are able to spread over inert albumin 
regions and the morphology isn’t necessarily dependent on the underlying 
fibrinogen pattern.  
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(Figure 4.2, row 1) while the adhered platelets were observed using DIC 
microscopy (Figure 4.2, row 2). Corresponding images were superimposed to 
study the spatial registration between the platelets and the underlying protein 
features (Figure 4.2, row 3).  At 20% fibrinogen coverage almost no spreading 
was observed (Figure 4.2a).  The size of the platelets was small, their shape 
rounded.  When platelets did spread, their morphology was strictly limited by the 
size of the underlying fibrinogen islands. At 50% fibrinogen coverage, more 
extensive platelet spreading was observed; however, morphology was still 
dependent on the shape of the underlying pattern (Figure 4.b).  At 85% 
fibrinogen coverage, fibrinogen islands coalesced into a continuous 
interconnected pattern and extensive spreading was observed. In most cases, 
platelets spread over the blocked albumin islands as well (Figure 4.3c).  This 
may be due to the full interconnectivity of fibrinogen patterns at this level of 
surface coverage. Once platelets adhered, a path around the small inert albumin 
islands was available to facilitate spreading. Interactions between fibrinogen and 
integrin αIIbβ3 receptors on the platelet membrane are critical in signaling 
cytoskeletal reorganizational events [167]. Therefore spreading may also be 
dependent critical number of ligand-protein interactions being achieved. 
Platelet shape change facilitates activation mechanisms crucial in 
ensuring the proper hemostatic response.  Spreading induces αIIbβ3 activation 
and cytoskeletal reorganization events that lead to platelet degranulation and 
amplification of the coagulation response [167,79,168].  Filipod formation 
facilitates platelet-fibrin interactions and aggregation while lamellipod formation is 
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crucial in arresting vascular leakage upon vessel injury [168,219].  In vitro 
vascular injury models are commonly used to understand fundamental 
coagulation mechanisms.   Specifically, the platelet response and thrombus 
formation has been investigated on surfaces preadsorbed with agonists such as 
collagen, fibrinogen and vWf [58,220,221]. It has been demonstrated that both 
fibrinogen and vWf are capable of mediating platelet adhesion and aggregate 
formation through synergistic interactions between integrin αIIbβ3 and GPIb-X-IV 
[43,46].  
The ability to control the type and size of platelet activating ligand patches 
can be used to correlate morphological parameters with physiological events 
such as exposure of a small lesion in the vascular endothelial layer to circulating 
blood. The lesion size determines the number of ligands available for platelet 
activation and subsequently the stimuli requirements for receptor 
expression/distribution, intracellular calcium changes, and secretion of platelet 
recruiting agents. Thus, the techniques described here could be applied to 
physiologically relevant binary protein models, for example collagen-vWf, or 
fibrinogen-vWf, and used to study the mechanisms involved in these processes.  
Immobilized protein patterns have been used to capture platelets in whole blood 
for other applications [152,153]. Thus these methods could be applied to whole 









4.3.3 Quantifying the Effect of Relative Fibrinogen Coverage  
on the Platelet Response 
 
In order to quantify the platelet response, adhesion, spreading area and 
circularity were measured for each fibrinogen surface coverage (20%, 50%, and 
85%). Average adhesion was calculated for each sample (Figure 4.3a, n=30).  
Values were compared with a 100% fibrinogen substrate prepared using by 
printing flat PDMS stamp. Platelet adhesion to the albumin background was also 
measured but found to be negligible (data not shown).  Overall adhesion 
increased with increasing fibrinogen surface  coverage  demonstrating  that  the 
random  island  printing can  be used  as  a means to titrate the adhesion 
response. 
Average platelet spreading area is shown in Figure 4.3b.  Average 
spreading area increased with increasing fibrinogen surface coverage (i.e., with 
increased size of the underlying fibrinogen islands).  At 20% relative fibrinogen 
coverage, almost no spreading was observed and the average area per platelet 
was 9.1 +/- 0.7 µm2.  Compared with the average fibrinogen feature size of 5.3 
+/- 0.4µm2 (Table 4.1) it appeared that the platelets formed stable adhesion only 
on larger fibrinogen islands.  Platelet spreading area increased with increasing 
fibrinogen surface coverage to 50% equaling 38.9 +/- 3.6 µm2; an area which 
was less than half of the average size of the coalesced fibrinogen island (Table 
4.1).  For this fibrinogen surface coverage, the shape of the platelets was 
strongly affected by the shape of fibrinogen islands (Figure 4.3b).  At 85% 
fibrinogen coverage, spreading area was 48.2 +/- 5.0 µm2.   The increase in 





Figure 4.3 Quantification of the platelet response to fibrinogen micropatterns: (A) 
Platelet adhesion to printed fibrinogen substrates at 20%, 50% 85% and 100% 
relative surface coverage (n=30). Nexterion-H slide covered with albumin showed 
negligible platelet adhesion (data not shown).  (B) Average platelet spreading 
area on samples with each relative fibrinogen coverage (n = 100). (C) Average 
platelet circularity for each relative fibrinogen coverage (n = 100).  All error bars 
represent the standard error of the mean with a 95% confidence interval. 
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than between 50% and 85% though all were significantly different (p < 0.001).   
Circularity has been recognized as a way to quantify the platelet 
morphological response [222,223]. Upon activation, the circularity will approach 
one as platelets reach their fully spread morphology [223]. In order to determine 
the extent in which spreading was affected by the underlying fibrinogen pattern, 
circularity was calculated (n=100) for each sample. If circularity is less than one 
the platelet shape was irregular with lower values corresponding to shapes that 
were less circular.  At 20% and 85% relative fibrinogen coverage, there was no 
significant difference in circularity (Figure 4.3c).  This is not surprising because 
although there was a significant difference in spreading area, both adhered and 
fully spread platelets display circular morphologies. At 50% relative fibrinogen 
coverage a significant (p<0.001) decrease in circularity was observed.  This was 
due to the shape of the underlying fibrinogen pattern supporting only irregular 
morphologies, not allowing the platelets to spread fully (also seen in Figure 4.3b). 
 
4.3.4 Assessment of Platelet Morphological Parameters 
 
Following platelet activation, intracellular signals induce platelet spreading.  
This is also accompanied by an increase in intracellular Ca2+ levels, thrombin 
activation and platelet granule secretion [166,79,224]. As a result, platelet 
morphology is often used as a method to qualitatively assess the level of surface 
induced platelet activation. In order to further investigate the effect of varying 
fibrinogen feature sizes on platelet morphology, high resolution SEM images 









Figure 4.4 Scanning electron micrograph images of platelets spreading on 
surfaces printed at (A) 20%, (B) 50% and (C) 85% relative fibrinogen coverage 















no spreading occurred and platelets displayed small spherical morphology.  In 
some cases, however, platelet filopods were observed suggesting that these 
adhesion events still resulted in activation and may support platelet recruitment 
and aggregation over time.   Samples with 50% fibrinogen coverage (Figure 
4.4b), exhibited more extensive spreading and filipod formation but morphologies 
were irregular in shape. As discussed above this is the result of the underlying 
pattern restricting platelet spreading to regions in which immobilized fibrinogen is 
present (Figure 4.3b).  At 85% coverage (Figure 4.4c) extensive spreading 
occurred and more platelets were observed to be in a fully spread circular shape. 
Platelet activation and morphology are interrelated; as a result, shape 
change was qualitatively assessed by examining the extent of fillipod formation 
and spreading for each sample (Table 4.2).  Activation levels were divided into 
four stages: 1) adherent but no apparent morphological changes, 2) initial 
formation of filopods,  3) extensive filipod formation and beginning of spreading, 
and 4) filopod retraction and flat rounded morphologies. SEM images (n=10) for 
each relative fibrinogen coverage were examined.  The number of platelets in 
each category was calculated and normalized by the total number of adhered 
platelets.  These values were then averaged to give an overall mean percent and 
standard error for each sample. The number of platelets that adhered but 
showed no apparent morphological changes and the number of platelets that 
showed initial stages of filipod formation decreased with increasing fibrinogen 








Table 4.2 Qualitative assessment of platelet activation based on the morphology 
of adherent platelets (n = 10). 





and maintain a 
small spherical 
morphology 









a round flat 
morphology 
20% 37.0% +/- 8% 63.0% +/- 8% 0% 0% 
50% 2.5% +/- 2.1% 21.7% +/- 4.9% 63.1% +/- 4.5% 12.7% +/- 2.4% 


















rounded flat morphologies increased at higher fibrinogen area fractions.  In fact, 
at 20% coverage, no platelets in the third or fourth stages of activation were 
observed.  These results all suggest that overall platelet activation can be 
controlled by varying the size of the fibrinogen islands. 
Morphology has been demonstrated as an important variable in controlling 
many different cellular events [118,120,136]. For example, Chen et al. used μCP 
of extracellular matrix ligands to restrict endothelial cell spreading that resulted in 
an increase in apoptosis [47]. Cytoskeletal reorganization events have also been 
implicated in many platelet activation mechanisms [166-168]; however, the use of 
micropatterned substrates to control platelet morphology is relatively unexplored. 
Given that platelet spreading is mediated by integrin-protein interactions, 
Grunkemeier et al. explored the role of different protein ligands in spreading 
mechanisms.  Specifically, they investigated possible synergistic platelet shape 
change mechanisms by comparing spreading on polystyrene surfaces 
preadsorbed with a binary vWf-fibrinogen mixture, with  homogeneous  controls.   
More  spreading  was  observed  on the  binary   protein surface suggesting a 
synergistic role in platelet spreading; however, because the proteins were 
adsorbed, specific local protein-platelet effects could not be visualized [225].  The 
techniques presented here will facilitate future studies investigating these 










This study demonstrated that the surface induced platelet response could 
be controlled by the size and shape of immobilized protein ligands.  Specifically, 
µCP was used to produce randomly placed, covalently immobilized, µm-sized 
fibrinogen islands at three different surface coverage areas as characterized by 
fluorescence and lateral force microscopy.  It was found that the fibrinogen island 
number, size and shape affected both platelet adhesion and morphology.  Also, 
these effects could be titrated by varying overall fibrinogen coverage.   The 
ubiquitous nature of the immobilization procedure allows the same technique to 
be applied to any protein of interest and may serve to study additional local 




SUMMARY, PERSPECTIVES AND FUTURE DIRECTIONS 
 
 
5.1 Summary and Perspectives 
 
The search for a hemocompatible material has been a primary research 
endeavor in the field of biomaterials for over 50 years.  Despite this incredible 
effort, no truly blood compatible material has been developed and the conflicts on 
how to approach the issue only seem to magnify.  Platelet-material interactions 
have been a central focus in hemocompatibility due to their multifaceted roles in 
thrombus formation, inflammation, neointimal hyperplasia formation and immune 
responses.  As a result, a principal research goal has been to tailor biomaterial 
surface properties to be inert to platelet adhesion and activation.  Countless 
techniques have been employed to achieve this goal.  In fact, if “biomaterial” and 
“reduced platelet adhesion” are entered into a Google Scholar search, 
approximately 1000 results are returned since 1995.  In the majority of these 
publications, the researchers were capable of reducing platelet adhesion and/or 
activation on a novel surface of some variety.  With this apparently large success 
rate, it is not unreasonable to ask, why is there a still lack of suitable materials for 
blood-contacting medical applications? 
The physiological platelet response to a site of vascular injury or 
abnormality is inherently designed to be amplified. Thus, even the slightest
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amount of material induced platelet activation can lead to aggregation and 
thrombus formation.   Although the ability of novel materials to reduce the platelet 
response is an exciting outcome in fundamental research studies, these 
materials will not attain long term in vivo success unless the platelet response is 
completely attenuated.  The sensitivity of platelets to varying stimuli and the 
complexity of the governing physiological processes make this a challenging 
task.   
One crucial dilemma is that our basic understanding of fundamental 
platelet adhesion and activation mechanisms is still quite incomplete.  This has 
led us to potentially false conclusions.  For example, for many years, the ability of 
surfaces to minimize or eliminate fibrinogen adsorption was viewed as a key 
criterion to improve blood compatibility.  However, more recently, it has been 
found that the adsorbed conformation of fibrinogen rather than the amount is a 
more critical determinant in the platelet response [34,36,204,206].  Also, albumin 
has been believed to be inert to platelet adhesion and has been extensively 
studied as potential blood-compatible surface coating [37,38,104,105,226].  
However, Sivaraman et al. recently discovered that albumin is, in fact, capable of 
supporting platelet adhesion in vitro and that this may be due to the 
conformational dependent exposure of a binding epitope for platelets [35].   It is 
important we focus on decoding these fundamental cause and effect 
relationships that both drive and inhibit material induced platelet activation before 
we hastily screen and implant potential blood compatible materials into in vivo 
models.  The development and use of these models is not only expensive but the 
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mechanism of failure/success is difficult to elucidate; this is because the 
physiological response is complex and highly interwoven. 
The goal of the work described in this dissertation was to develop tools 
that allow for the study of fundamental platelet adhesion and activation 
mechanisms and well-defined control over the surrounding environment in which 
platelets were exposed was of paramount importance.  In Chapter 2, a versatile 
negative charge density chemical gradient was developed to rapidly screen 
protein and platelet-surface interactions over a well defined variety of surface 
chemistries.  These gradients not only provide a well-defined surface 
microenvironment but also provide a combinatorial advantage over 
homogeneous testing methods.  Gradients were prepared by selective oxidation 
of a thiol monolayer to negatively charged sulfonate groups.  The gradient 
surfaces were preadsorbed with three different protein solutions (plasma, 
albumin and fibrinogen) and the platelet response in flow conditions was 
assessed.  Platelet adhesion patterns were found to be dependent on both the 
type and concentration of the adsorbed protein layer as well as the surface 
charge.  However, when the orientation of the gradient was reversed, the 
adhesion patterns were not conserved.  This indicated the response may not only 
be due to local effects, but instead, may be a result of upstream platelet-surface 
interactions.  This observation was further confirmed by a significant increase in 
platelet adhesion seen over the length of homogeneous fibrinogen preadsorbed 
samples as a function of distance from the flow inlet.  In order to effectively use 
these gradients as a screening tool, the effect of upstream platelet-surface 
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interactions on the downstream response needs to be addressed.  Potential 
solutions to this problem are outlined in the future directions section of this 
dissertation (section 5.2).    
As outlined in Chapter 3, the potential of upstream agonists to “prime” 
platelets for downstream adhesion and activation has both clinical implications 
and can affect the design of in vitro blood compatibility studies.   Here we 
hypothesized that agonists, such as immobilized fibrinogen, were capable of 
priming platelets for downstream adhesion and activation.  This hypothesis was 
tested by immobilizing fibrinogen in well-defined “priming” and “capture” regions 
using µCP on reactive PEG based substrates.  The presence of the priming 
region on downstream platelet adhesion, spreading area, and aggregation was 
quantified.  It was found that each variable - adhesion, spreading area, and 
aggregation - was significantly higher on samples that contained a fibrinogen 
priming region compared to control samples.  The effect of fibrinogen priming on 
bulk platelet activation was also assessed using flow cytometry. 
In Chapter 4, the ability of well defined protein micropatterns to control 
variables such as platelet adhesion and spreading was explored.  Random 
fibrinogen micropatterns were covalently immobilized to reactive substrates at 
three different coverage areas using µCP.  The background region was 
passivated with covalently immobilized albumin.  Changing the relative coverage 
area resulted in a change in the size distribution of the features of the fibrinogen 
patterns.  We found that the immobilized fibrinogen coverage area was directly 
related to the platelet adhesion response.  Platelet morphology was controlled by 
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the size and shape of the fibrinogen microfeatures up to a certain point.  At high 
coverage areas, the fibrinogen features were completely interconnected and 
platelets were capable of spreading over the passivated albumin background 
regions.  The ability to control the ligands presented to platelets as well as its 
morphology will facilitate future fundamental studies focused on deciphering the 
mechanisms responsible for surface induced platelet activation. 
 
 
5.2 Future Directions 
 
In Chapter 2, the use of chemical gradients was explored as a high 
throughput method to screen protein and platelet-surface interactions.  
Specifically, negative charge density gradients were prepared by selective 
oxidation of a thiol monolayer to negatively charged sulfonate groups.  The 
platelet response with different preadsorbed protein substrates was assessed.  
Platelet adhesion patterns were found to be dependent on both the type and 
concentration of the adsorbed protein layer as well as the surface charge.  
However, when the orientation of the same gradient sample was reversed, the 
adhesion patterns changed.  This indicated the response may not be due to local 
effects only but instead may be a result of upstream platelet-surface interactions.   
The initial goal of this study was to use gradients to rapidly screen both 
the protein and platelet response to various molecular environments.  The 
discovery that upstream platelet interactions with the surface affect downstream 
adhesion patterns presents a challenge that needs to be addressed.  If upstream 
interactions elicit a downstream response, there is no way to decipher if the local 
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platelet response is a direct result of the surface properties of that region, or an 
artifact of upstream platelet-surface interactions. 
One potential solution is to redesign the patterning chamber to produce 
gradients in a perpendicular orientation to the flow direction.  This will ensure that 
platelets encounter the same conditions throughout the perfusion.  There still 
does exist possibility that platelet activity will increase along the length of the 
sample. Therefore results should always be compared and/or normalized to a 
homogeneous control.   
After ensuring upstream effects are accounted for, these surface gradients 
provide a useful means to rapidly identify cause and effect relationships between 
properties of the surface microenvironment and the protein/platelet response.  
Detectable changes observed in the platelet or protein behavior can be exploited 
and studied in greater detail on homogeneous test samples.  
One unique advantage of the described molecular surface gradients is 
their versatility.  The negatively charged sulfonate groups are relatively inert to 
further modification; however, thiol moieties can be utilized for a variety 
secondary reactions making these gradients foundation for a variety of screening 
studies.  For example, zwitterionic surface properties have shown improved 
hemocompatibility [111,161,227,228]; however, the exact reason for this is not 
completely understood. Variables such as the relative positive/negative surface 
charge density can be explored using positive to negatively charged gradients.  
These can be prepared using idoacetamides, such as Aminoethyl8™ (Thermo 
Scientific), which convert the neutral       thiol surface to a positively charged 
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amine surface. The iodoalkyl group on Aminoethyl8™ specifically reacts with 
thiol groups via a covalent thioether bond [229].   The thiol groups can also be 
modified with compounds such as idoacetate which contain a terminal hydroxyl 
group and subsequently will create different surface dipoles on the gradient 
surface [230].  Heterobifunctional crosslinkers, such as sulfo-SMCC, can be 
conjugated to thiols [189, 190] forming protein reactive terminal NHS ester 
groups and can be used to develop a variety of protein/enzyme gradients.  PEG 
is a versatile polymer that can be reacted with surfaces, proteins, and other 
biomolecules, and has been specifically immobilized to surfaces using silane 
conjugation techniques [231, 232].   PEG based substrates are not only highly 
resistant to nonspecific protein adsorption [230] and cell adhesion but the use of 
PEG spacers in the immobilization of biomolecules, such as heparin, has been 
shown to improve its thromboresistant activity [116, 112, 113].    This is likely 
because the long brush like PEG chains allow the 3-dimensional structure and 
mobility of biomolecules to be maintained [112, 116].  Gradients of PEG based 
biomolecule immobilization schemes can be used to optimize variables 
contributing to its blood compatibility such as surface distribution/density. 
In Chapter 3, we discovered that upstream fibrinogen was capable of 
priming platelets for downstream adhesion and activation.  In the future, it will be 
important to characterize if other agonists are also capable of eliciting such a 
response.  For example, collagen is exposed at the suture site of implanted 
vascular devices and is known to locally promote platelet adhesion and activation 
[65,234] and therefore may also be capable of priming platelets for downstream 
125 
 
activation.  It would also be interesting to explore potential synergistic 
interactions in these mechanisms by introducing soluble agonists such as vWf 
into the system.   
In Chapter 4, fibrinogen micropatterns at varying surface coverage areas 
were prepared and found to exhibit control over platelet morphological 
parameters.  As discussed in section 1.2.3, platelet morphological changes are a 
key characteristic of platelet activation. Platelet contacts with surface adsorbed 
proteins induce cytoskeletal rearrangements that facilitate spreading [79,166-
168].  Also, the resulting geometry allows for the centralization of secretion 
granules and more secretion events have been observed when platelets are in 
their fully spread state [79].  Consequently, platelet morphological assessments 
are commonly used to qualitatively assess biomaterial induced platelet activation.  
One future study currently being designed is to establish a quantitative 
relationship between key platelet morphological parameters and degranulation, a 
central event in platelet activation.    Logically, platelet spreading area may be 
directly related to secreted activation markers. This will be accomplished by 
printing random fibrinogen micropatterns at three relative surface coverage areas 
and measuring the release of β-thromboglobulin from the α-granules of the 
spreading platelets using a commercially available ELISA kit.  These values will 
be correlated with platelet spreading area and circularity using SEM analysis, two 
variables often used to qualitatively assess biomaterial induced platelet 
activation.   The goal is to develop a quantitative relationship between these 
parameters and degranulation. 
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To date, binary patterns of fibrinogen and albumin have been used by our 
group.  The procedures used in Chapter 4, however, could be applied to any 
binary system of proteins leaving open the possibility for platelet spreading 
studies with a variety of protein substrates.  For example, vWf/fibrinogen, 
collagen/vWf, or collagen/fibrinogen, patterns could be used to study synergistic 
interactions between these proteins during activation.  Also, the relative amount 
of each protein could be titrated and used to quantify if a threshold is associated 
with a given response.  The ubiquitous nature of this protein immobilization 
scheme allows for the described techniques to be applied to a wide variety of 











In Chapter 2, sulfo-SMCC modified MTS monolayers were used to 
prepare covalently immobilized fibrinogen test samples.  Procedures used in this 
study were adapted from previous protocols developed in our lab in which RGD 
peptides were successfully immobilized using this chemistry.  Here, XPS analysis 
of the modification of MTS monolayers with sulfo-SMCC is presented. Elemental 
composition (C, O, N, S, and Si) for an MTS thiol monolayer was compared 
before and after sulfo-SMCC incubation.   These samples were also compared 
with oxidized MTS samples treated sulfo-SMCC as a negative control.  Three 
spots for each sample were analyzed using a Surface Science Instruments x-
probe spectrometer.  
There was a slight amount of nitrogen observed on both nonoxidized and 
oxidized samples prior to sulfo-SMCC treatment possibly due to outside 
contamination.  However, the elemental nitrogen and carbon atomic percentage 
both increased after sulfo-SMCC incubation on nonoxidized samples while the 
nitrogen content on oxidized samples actually decreased. The Si and O 
                                                 
1
 Mishra and Hlady, Unpublished Data 
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percentage (most likely due to the substrate signal) decreased which is 
consistent with addition of the molecule to the surface.   
The ability to immobilize RGDs to reactive sulfo-SMCC modified samples 
was also investigated.  No change in the relative atomic composition was 
observed prior and after RGD immobilization.  This is not surprising since no new 
atoms were introduced into the samples after RGD treatment thus XPS alone, 
insufficient in characterizing RGD surface modification. 
To further investigate RGD immobilization to sulfo-SMCC activated MTS 
monolayers, ToF-SIMS was used to detect amino acid fragments from the amino 
acids arginine, aspartic acid, and serine (Figures A.1 and A.2).  A significant 
increase in these fragments was observed on sulfo-SMCC activated non-
oxidized thiol monolayers versus oxidized control surfaces suggesting RGD 
















Table A.1 Atomic percentage (composition) as determined by XPS.  Three spots 
per sample were taken.  The average composition for each sample is reported 
along with the standard deviation. 
 
    Atomic Percentage 
Sample     C O N S Si 
MTS Unoxidized 
 
AVG 32.2 39.5 0.6 3.3 24.5 
  
STDV 0.9 0.6 0.1 0.1 0.8 
        MTS Fully Oxidized 
 
AVG 27.8 45.5 1.5 1.7 23.6 
  
STDV 2.3 1.8 0.2 0.3 0.8 
        MTS + sSMCC 
Unoxidized 
 
AVG 43.6 33.3 2.8 2.9 17.5 
  
STDV 0.7 0.5 0.1 0.5 0.5 
        MTS + sSMCC 
Oxidized 
 
AVG 22.2 48.6 0.7 1.1 27.4 
  
STDV 0.8 1 0 0.3 0.6 
        with RGD Unoxidized 
 
AVG 43 33.4 2.6 3.2 17.8 
  
STDV 1.3 1 0.1 0.2 0.5 
        With RGD Oxidized 
 
AVG 24 48.1 0.9 0.9 26.6 
    



















Figure A.1 Positive ToF-SIMS spectra of m/z 100.1 C4H10N3 fragment (shown to 
be indicative of the amino acid arginine [239].  Spectra have been normalized to 
























































Figure A.2 Positive ToF-SIMS spectra of m/z 88.0 region. The C3H6NO2 fragment 
has been reported to be indicative ot the amino acid aspartic acid [239].  Spectra 



































DERIVATION OF LEVICH APPROXIMATION 
 
 
In order to determine the number of platelets that are capable of 
interacting with the surface we estimated the convective/diffusive driven flux of 
the platelets to the surface using the Smoluchowski-Levich approximation.  Here, 
the flow –induced transport of colloidal particles to an interface can be described 
by a convective-diffusion equation.  Assuming an absence of interaction forces 




   
  
  
   
  
  
   
   
   
 
   




The solution for velocity in the x direction of a parallel plate flow cell [200, 202]: 
 
 













Vm = the mean velocity 
b = ½ the depth of the flow cell 
 
In our system, the platelets are constantly being supplied to the flow 
chamber at a concentration of 2.5*107 platelets/ml (~25% of physiological 
concentration). Thus no decrease in concentration over time is observed in the 






   
 
 
The dimensionless form of this equation is given by the Peclet (Pe) number 
which represents the ratio between diffusion and convective mass transport: 
 
 
    






L = characteristic length of the system  
u0 = characteristic velocity 
 













   
   
 
   





X = x/L 
Y = y/L 
Vi = vi/u0 
C = c/cbulk 
 
After substitution of vx in the equation we get: 
 
 
   
   

















For simplicity during integration we substitute: 
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After double integration with respect to the bulk concentration we get 
 
 
          











By applying Ficks law for diffusion we get 
 
 
     
  
  
       
   




   
  








   
     
 
   
       
 
 
The deposition rate is often represented as a dimensionless quantity called the  
 
Sherwood number, Sh, where: 
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 j0 = initial deposition rate 
D = Diffusion coefficient 
c = bulk concentration 
Pe = the dimensionless Peclet number (Adamczyk and van de Ven) for flow 
deposition of colloidal particles in a parallel plate flow cell [202, 203]. 
 
    
    
 





a = the platelet radius 
X = x/b where x is the distance from the flow inlet and b is ½ the height of the 
flow cell.  
 
For the system described in Chapter 3: 
 
 c = 2.5*107 plt/cm3 Vm = 0.44 cm/sec  μ = 1 kg/m*sec 
 T = 310.15 K  a = 10-6 m   b = 0.025 cm 
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The Peclet for the system is: 
 
 
    
    
 






      
  
    
         
                 
   
    
 
 
        
 
 
The flux as a function of distance from the flow inlet is (See Figure 3.8):  
 
    
     
    
 
   
     
 




        
    
















EFFECT OF PROTEIN IMMOBILIZATION SCHEME ON  
 





Fibrinogen has been implicated in being essential for stable platelet 
adhesion to biomaterials [41,72]. Subsequently, platelet-fibrinogen interactions 
have been studied extensively.  When fibrinogen adsorbs to the surface, 
epitopes within the molecule are exposed that bind to the integrin αIIbβ3 on the 
platelet membrane. This interaction converts platelets to an active state in which 
they begin to spread and recruit more platelets. It has been shown that surface 
distribution, concentration, and conformation can all affect the platelet response 
[36,176,204,205,207,222,235]. In fact, conformation is believed to be of critical 
importance since in its soluble form, fibrinogen is relatively inert to platelets when 
no agonists are present [34,42].  
Surface patterning is a technique used to study protein-cell and protein-
platelet interactions. There many different approaches to patterning protein on a 
surface including direct methods such as inkjet deposition [236] and micro-
contact printing [135, 145,150,237,238], as well as indirect methods involving site 
specific adsorption using custom designed microfluidic chambers [135,145,153]. 
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The value in surface patterning lies in the ability to precisely control the 
type, concentration and distribution of the protein on the surface.  Surface 
patterning has also been coupled with the use of reactive surface chemistry 
capable of covalently immobilizing the protein to the surface. This not only 
increases the stability of the surface but also allows for patterning of surfaces 
that are resistant to protein adsorption. 
Although patterned surfaces show great promise in studies relating to 
platelet adhesion, activation and spreading as well as promise in being used as 
tools for platelet screening assays. The effects of the patterning technique on 
fibrinogen conformation and platelet adhesion have not been well documented. 
In this work we examined how different methods of protein immobilization 
affected the platelet response. Two protein reactive substrates were compared; 
sulfo-SMCC activated quartz, and NHS ester activated Nexterion-H slides 
(preparation methods discussed in section 3.2). Fibrinogen was immobilized on 
each sample by passive adsorption as well as µCP.  We found that the platelet 
response and the relative amount of protein immobilized on each sample were 
significantly different depending on the immobilization technique.  The platelet 
response, however, did not directly correlate with the amount of adsorbed 
fibrinogen suggesting other factors such as protein conformation may be 








C.2.1 Preparation and Characterization of  
Fibrinogen Immobilized Surfaces 
Preparation of sulfo-SMCC reactive surfaces followed protocols outlined in 
section 3.2.1.  Passive immobilization was carried out by incubating both sulfo-
SMCC and Nexterion-H (Schott) reactive substrates with human fibrinogen 
(Calbiochem) in 0.1 M PBS (c = 0.1 mg/ml, 1 mg/ml or 10 mg/ml) for 45 minutes.  
Printed fibrinogen substrates were prepared following protocols outlined in 
section 3.2.2 using µCP at a 100% relative coverage area.  Following 
immobilization, samples were vigorously rinsed in a 1% Tween surfactant 
solution to remove protein not covalently bound to the surface.  Samples were 
dried with N2 gas and then stored under vacuum until use. 
 
C.2.2 Washed Platelet Preparation and Adhesion Studies 
 
 Washed platelets were prepared as described in section 3.2.6 in a 
Tyrodes-HEPES buffer (c = 107 platelets/ml).  Platelets were perfused over each 
sample for 5 minutes in a parallel plate flow cell as described in section 2.2.5.  
DIC microscopy was used to visualize platelet adhesion on each sample.  
Average adhesion was quantified (n=30) and significance was calculated using 
unpaired t-tests.   
 
C.2.3 Quantifying Relative Amount of Surface Immobilized Fibrinogen 
 
 The relative amount of surface immobilized fibrinogen was calculated by 
measuring the mean fluorescence intensity (n = 30) of Alexafluor-488 labeled 
fibrinogen after protein immobilization (see section 3.2.4 for labeling protocol).  
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C.3.1 Effect of Surface Chemistry and Protein Immobilization 
Scheme on Platelet Adhesion 
 
Overall average platelet adhesion was compared on fibrinogen surfaces 
prepared using two different patterning techniques (passive immobilization, direct 
printing) on substrates with two different protein immobilization chemistries 
(sulfo-SMCC modified quartz, NHS activated PEG based hydrogel).  It was found 
that the platelet adhesion response was different depending on both the 
patterning technique and the immobilization chemistry for three different 
concentrations of fibrinogen in solution (Figures C.1 and C.2).   
 Although the fibrinogen solutions used at the beginning of the patterning 
process were all at equal concentrations, the efficiency of the protein transfer 
may not be the same for each technique or immobilization chemistry.  Thus, the 
relative amount of fibrinogen was measured by quantifying fluorescence intensity 
of Alexa Fluor-488 labeled fibrinogen for each sample (Figure C.3).  All values 
were normalized against background fluorescence for each sample.  It was found 
that the amount of relative fibrinogen on the surface for each sample was, in fact, 
different.  However, when the relative amount of fibrinogen was plotted against 
average platelet adhesion, no direct correlation could be established (Figure 
C.4). This suggests that other factors may contribute to the variation in platelet 






Figure C.1 The effect of the protein immobilization technique on platelet adhesion 
to Nexterion-H substrates.  Fibrinogen was either printed on or adsorbed to the 
reactive substrates at three concentrations.  Overall platelet adhesion was 
significantly different (n = 30, p < 0.001) on printed versus passively immobilized 
















Figure C.2 The effect of the protein immobilization technique on platelet adhesion 
to sulfo-SMCC activated quartz slides.  Fibrinogen was either printed on or 
adsorbed to the reactive substrates at three concentrations.  Overall platelet 
adhesion was significantly higher (n = 30, p < 0.001) on passively immobilized 














Figure C.3 The relative amount of fibrinogen immobilized to each sample 
measured by fluorescence intensity.  For each immobilization scheme 30 
samples were averaged and normalized against the background fluorescence.  
















Figure C.4 The relationship between overall platelet adhesion and relative 
amount of immobilized fibrinogen for sulfo-SMCC and Nexterion-H samples 

















Here, we observed significant changes in platelet adhesion patterns on 
immobilized fibrinogen surfaces.  The immobilization process (passive or 
printing) as well as the underlying surface chemistry both was observed to play a 
role.  When we investigated the relative amount of fibrinogen immobilized to the 
surface using fluorescence microscopy we found that there in fact was different 
surface protein concentrations depending on the immobilization procedure.  
However, when the relative fibrinogen concentration was plotted against platelet 
adhesion, no direct relationship was observed.  This suggests other factors may 
be affecting the platelet response including the immobilized fibrinogen 
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